Quick viewing(Text Mode)

Patient-Formulary.Pdf

Patient-Formulary.Pdf

Sandwell and West Birmingham Hospitals NHS Trust

Sandwell and West Birmingham Clinical Commissioning Group

Formulary

The drugs contained in the formulary of Sandwell and West Birmingham Hospitals Trust are listed below.

NICE considers that the benefits of a local formulary include

• improving patient outcomes by optimising the use of medicines; • supporting the inclusion of patient factors in decision-making about medicines; • improving local care pathways; • improving collaboration between clinicians and commissioners; • improving quality by reducing inappropriate variations in clinical care; • improving quality through access to cost-effective medicines; • supporting the supply arrangements of medicines across a local health economy; • supporting financial management and expenditure on medicines across health communities; • supporting prescribers to follow guidance published by professional regulatory bodies in relation to medicines and prescribing.

Drugs marked in black text are available for general use and may be prescribed by any prescriber in the Trust

Drugs marked in orange as “restricted” are available for use in restricted circumstances; they may be restricted to certain specialties, or for treating certain diseases, or for use when first-line treatment has not worked. Where clinically appropriate, prescribing of restricted drugs may be passed to primary care on the advice of a specialist.

Drugs which are approved by NICE in a technology appraisal are available for use in the Trust. All other drugs are available on Consultant request provided the request is authorized by a medical director or an officer of the Drug and Therapeutics committee.

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 and ->Aluminium- and -containing antacids HYDROXIDE On Formulary 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Aluminium- and magnesium-containing antacids MAGNESIUM TRISILICATE On Formulary

1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Aluminium- and magnesium-containing antacids->ALUMINIUM HYDROXIDE Co-magaldrox On Formulary 1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Aluminium- and magnesium-containing antacids->ALUMINIUM HYDROXIDE->Co- magaldrox Maalox® On Formulary

1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Aluminium- and magnesium-containing antacids->MAGNESIUM TRISILICATE Magnesium Trisilicate Mixture, BP On Formulary

1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.1 Antacids and simeticone->Simeticone alone Infacol® Restricted

1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary preparations->Alginate raft-forming oral suspensions Peptac® On Formulary

1 Gastro-intestinal system->1.1 Dyspepsia and gastro-oesophageal reflux disease->1.1.2 Compound alginates and proprietary indigestion preparations->Other compound alginate preparations Gaviscon Infant® Restricted 1 Gastro-intestinal system->1.2 and other drugs altering gut motility Motility stimulants On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Antimuscarinics SULFATE On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Antimuscarinics On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Antimuscarinics->ATROPINE SULFATE Atropine On Formulary

1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Antimuscarinics->HYOSCINE BUTYLBROMIDE Buscopan® On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Other antispasmodics HYDROCHLORIDE On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Other antispasmodics PEPPERMINT OIL On Formulary 1 Gastro-intestinal system->1.2 Antispasmodics and other drugs altering gut motility->Other antispasmodics->MEBEVERINE HYDROCHLORIDE Mebeverine Hydrochloride On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2- antagonists On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.1 H2-receptor antagonists->RANITIDINE Ranitidine On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.4 analogues Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors LANSOPRAZOLE On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors OMEPRAZOLE Restricted 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->LANSOPRAZOLE Lansoprazole On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->LANSOPRAZOLE Zoton® Restricted 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->OMEPRAZOLE Omeprazole On Formulary 1 Gastro-intestinal system->1.3 Antisecretory drugs and mucosal protectants->1.3.5 Proton pump inhibitors->OMEPRAZOLE Losec® Restricted 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs On Formulary 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs HYDROCHLORIDE On Formulary 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs On Formulary 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs->LOPERAMIDE HYDROCHLORIDE Imodium® On Formulary 1 Gastro-intestinal system->1.4 Acute diarrhoea->1.4.2 Antimotility drugs->LOPERAMIDE HYDROCHLORIDE Loperamide On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates SULFASALAZINE On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates BALSALAZIDE Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->BALSALAZIDE SODIUM Colazide® Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Asacol® On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Asacol® MR On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Pentasa® On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->MESALAZINE Salofalk® On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.1 Aminosalicylates->SULFASALAZINE Sulfasalazine On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.2 On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.2 Corticosteroids Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.2 Corticosteroids->PREDNISOLONE->Rectal preparations Predsol® On Formulary 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response AZATHIOPRINE Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->Cytokine modulators ADALIMUMAB Restricted 1 Gastro-intestinal system->1.5 Chronic bowel disorders->1.5.3 Drugs affecting the immune response->Cytokine modulators- >INFLIXIMAB Preparations Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 1 Gastro-intestinal system->1.6 ->1.6.1 Bulk-forming laxatives ISPAGHULA HUSK On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.1 Bulk-forming laxatives METHYLCELLULOSE On Formulary

1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives SODIUM On Formulary

1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives On Formulary

1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives SENNA On Formulary

1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives On Formulary

1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives DANTRON Restricted

1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- With docusate sodium (as co- >DANTRON danthrusate) Restricted

1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- With poloxamer ?188? (as co- >DANTRON danthramer) Restricted

1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- >DANTRON->With docusate sodium (as co-danthrusate) Co-danthrusate Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- >DANTRON->With poloxamer ?188? (as co-danthramer) Co-danthramer Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- >GLYCEROL Glycerol Suppositories, BP On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- >SENNA Senna On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- >SENNA Senokot® On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.2 Stimulant laxatives- >SODIUM PICOSULFATE Sodium Picosulfate On Formulary

1 Gastro-intestinal system->1.6 Laxatives->1.6.4 Osmotic laxatives On Formulary

1 Gastro-intestinal system->1.6 Laxatives->1.6.4 Osmotic laxatives (RECTAL) On Formulary

1 Gastro-intestinal system->1.6 Laxatives->1.6.4 Osmotic laxatives SODIUM CITRATE (RECTAL) On Formulary

1 Gastro-intestinal system->1.6 Laxatives->1.6.4 Osmotic laxatives Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.4 Osmotic laxatives- >LACTULOSE Lactulose On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.4 Osmotic laxatives- >MACROGOLS Movicol® Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.4 Osmotic laxatives- >MACROGOLS Movicol® Paediatric Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.4 Osmotic laxatives- >PHOSPHATES (RECTAL) Fleet® Ready-to-use On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.4 Osmotic laxatives- >SODIUM CITRATE (RECTAL) Relaxit Micro-enema® On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.5 Bowel cleansing preparations->MACROGOLS Klean-Prep® On Formulary 1 Gastro-intestinal system->1.6 Laxatives->1.6.5 Bowel cleansing preparations->PHOSPHATES (ORAL) Fleet Phospho-soda® On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 1 Gastro-intestinal system->1.6 Laxatives->1.6.5 Bowel cleansing preparations->SODIUM PICOSULFATE WITH Picolax® Restricted 1 Gastro-intestinal system->1.6 Laxatives->1.6.7 Other drugs used in constipation NICE-approved 1 Gastro-intestinal system->1.7 Local preparations for anal and rectal disorders Management of anal fissures Restricted 1 Gastro-intestinal system->1.7 Local preparations for anal and rectal disorders Rectal sclerosants Restricted 1 Gastro-intestinal system->1.7 Local preparations for anal and rectal disorders->1.7.2 Compound haemorrhoidal preparations with corticosteroids Anusol-HC® On Formulary 1 Gastro-intestinal system->1.7 Local preparations for anal and rectal disorders->1.7.3 Rectal sclerosants PHENOL Restricted 1 Gastro-intestinal system->1.7 Local preparations for anal and rectal disorders->1.7.3 Rectal sclerosants->PHENOL Oily Phenol , BP Restricted 1 Gastro-intestinal system->1.7 Local preparations for anal and rectal disorders->1.7.4 Management of anal fissures GLYCERYL TRINITRATE Restricted 1 Gastro-intestinal system->1.7 Local preparations for anal and rectal disorders->1.7.4 Management of anal fissures->GLYCERYL TRINITRATE Rectogesic® Restricted

1 Gastro-intestinal system->1.9 Drugs affecting intestinal secretions acid sequestrants On Formulary 1 Gastro-intestinal system->1.9 Drugs affecting intestinal secretions- >1.9.1 Drugs affecting biliary composition and flow URSODEOXYCHOLIC ACID On Formulary 1 Gastro-intestinal system->1.9 Drugs affecting intestinal secretions- >1.9.1 Drugs affecting biliary composition and flow- >URSODEOXYCHOLIC ACID Ursodeoxycholic Acid On Formulary 1 Gastro-intestinal system->1.9 Drugs affecting intestinal secretions- >1.9.2 Bile acid sequestrants COLESTYRAMINE On Formulary 1 Gastro-intestinal system->1.9 Drugs affecting intestinal secretions- >1.9.4 Pancreatin->PANCREATIN Creon® 10?000 On Formulary 1 Gastro-intestinal system->1.9 Drugs affecting intestinal secretions- >1.9.4 Pancreatin->PANCREATIN Pancrex V® On Formulary 1 Gastro-intestinal system->1.9 Drugs affecting intestinal secretions- >1.9.4 Pancreatin->PANCREATIN Higher-strength preparations Restricted

1 Gastro-intestinal system->1.9 Drugs affecting intestinal secretions- >1.9.4 Pancreatin->PANCREATIN->Higher-strength preparations Creon® 25 000 Restricted 2 Cardiovascular system->2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides On Formulary 2 Cardiovascular system->2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides Digoxin-specific antibody Restricted 2 Cardiovascular system->2.1 Positive inotropic drugs->2.1.1 Cardiac glycosides->DIGOXIN Digoxin On Formulary 2 Cardiovascular system->2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase type-3 inhibitors Restricted 2 Cardiovascular system->2.1 Positive inotropic drugs->2.1.2 Phosphodiesterase type-3 inhibitors->ENOXIMONE Perfan® Restricted 2 Cardiovascular system->2.10 Stable angina, acute coronary syndromes, and fibrinolysis->2.10.2 Fibrinolytic drugs STREPTOKINASE On Formulary 2 Cardiovascular system->2.10 Stable angina, acute coronary syndromes, and fibrinolysis->2.10.2 Fibrinolytic drugs ALTEPLASE Restricted 2 Cardiovascular system->2.10 Stable angina, acute coronary syndromes, and fibrinolysis->2.10.2 Fibrinolytic drugs TENECTEPLASE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 2 Cardiovascular system->2.10 Stable angina, acute coronary syndromes, and fibrinolysis->2.10.2 Fibrinolytic drugs UROKINASE Restricted 2 Cardiovascular system->2.11 Antifibrinolytic drugs and haemostatics TRANEXAMIC ACID On Formulary 2 Cardiovascular system->2.11 Antifibrinolytic drugs and haemostatics->Blood-related products FRESH FROZEN PLASMA On Formulary 2 Cardiovascular system->2.11 Antifibrinolytic drugs and haemostatics->TRANEXAMIC ACID Tranexamic acid On Formulary 2 Cardiovascular system->2.12 Lipid-regulating drugs->Bile acid sequestrants COLESTYRAMINE On Formulary 2 Cardiovascular system->2.12 Lipid-regulating drugs->Bile acid sequestrants->COLESTYRAMINE Colestyramine On Formulary 2 Cardiovascular system->2.12 Lipid-regulating drugs->Ezetimibe EZETIMIBE Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Fibrates CIPROFIBRATE Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Fibrates FENOFIBRATE Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Fibrates- >FENOFIBRATE Fenofibrate Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Fibrates- >FENOFIBRATE Lipantil® Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Fibrates- >FENOFIBRATE Supralip® 160 Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Nicotinic acid group NICOTINIC ACID Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Nicotinic acid group->NICOTINIC ACID Modified release Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Omega-3 compounds OMEGA-3-ACID ETHYL Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Omega-3 fatty acid compounds->OMEGA-3-ACID ETHYL ESTERS Omacor® Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Statins SIMVASTATIN On Formulary 2 Cardiovascular system->2.12 Lipid-regulating drugs->Statins ATORVASTATIN Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Statins ROSUVASTATIN Restricted 2 Cardiovascular system->2.12 Lipid-regulating drugs->Statins- >SIMVASTATIN Simvastatin On Formulary 2 Cardiovascular system->2.13 Local sclerosants ETHANOLAMINE OLEATE Restricted 2 Cardiovascular system->2.13 Local sclerosants SODIUM TETRADECYL SULFATE Restricted 2 Cardiovascular system->2.13 Local sclerosants->ETHANOLAMINE OLEATE Ethanolamine Oleate Restricted 2 Cardiovascular system->2.2 Diuretics->2.2.1 Thiazides and related diuretics BENDROFLUMETHIAZIDE On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.1 Thiazides and related diuretics METOLAZONE On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.1 Thiazides and related diuretics INDAPAMIDE Restricted 2 Cardiovascular system->2.2 Diuretics->2.2.1 Thiazides and related diuretics->BENDROFLUMETHIAZIDE Bendroflumethiazide On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.1 Thiazides and related diuretics->INDAPAMIDE Indapamide Restricted 2 Cardiovascular system->2.2 Diuretics->2.2.1 Thiazides and related diuretics->INDAPAMIDE Modified release Restricted 2 Cardiovascular system->2.2 Diuretics->2.2.1 Thiazides and related diuretics->INDAPAMIDE->Modified release Natrilix SR® Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status 2 Cardiovascular system->2.2 Diuretics->2.2.2 Loop diuretics BUMETANIDE On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.2 Loop diuretics FUROSEMIDE On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.2 Loop diuretics- >BUMETANIDE Bumetanide On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.2 Loop diuretics- >FUROSEMIDE Furosemide On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.3 Potassium-sparing diuretics and antagonists AMILORIDE HYDROCHLORIDE On Formulary

2 Cardiovascular system->2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->Aldosterone antagonists On Formulary

2 Cardiovascular system->2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->Aldosterone antagonists EPLERENONE Restricted 2 Cardiovascular system->2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->Aldosterone antagonists- >SPIRONOLACTONE Spironolactone On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.3 Potassium-sparing diuretics and aldosterone antagonists->AMILORIDE HYDROCHLORIDE Amiloride On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.4 Potassium-sparing diuretics with other diuretics CO-AMILOFRUSE On Formulary 2 Cardiovascular system->2.2 Diuretics->2.2.5 Osmotic diuretics Restricted 2 Cardiovascular system->2.2 Diuretics->2.2.5 Osmotic diuretics- >MANNITOL Mannitol Restricted 2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for ->Supraventricular and ventricular arrhythmias AMIODARONE HYDROCHLORIDE On Formulary 2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Supraventricular and ventricular arrhythmias FLECAINIDE ACETATE Restricted

2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Supraventricular and ventricular arrhythmias HYDROCHLORIDE Restricted 2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Supraventricular and ventricular arrhythmias- >AMIODARONE HYDROCHLORIDE Amiodarone On Formulary 2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Supraventricular and ventricular arrhythmias- >FLECAINIDE ACETATE Flecainide Restricted 2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Supraventricular arrhythmias ADENOSINE On Formulary 2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Supraventricular arrhythmias->ADENOSINE Adenocor® Restricted 2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Ventricular arrhythmias LIDOCAINE HYDROCHLORIDE On Formulary 2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Ventricular arrhythmias->LIDOCAINE HYDROCHLORIDE Lidocaine On Formulary 2 Cardiovascular system->2.3 Anti-arrhythmic drugs->2.3.2 Drugs for arrhythmias->Ventricular arrhythmias->LIDOCAINE HYDROCHLORIDE Minijet® Lignocaine On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs FUMARATE On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs HYDROCHLORIDE On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs TARTRATE On Formulary

2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs HYDROCHLORIDE On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs Restricted 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs ESMOLOL HYDROCHLORIDE Restricted 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs HYDROCHLORIDE Restricted 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >ATENOLOL Atenolol On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >BISOPROLOL FUMARATE Bisoprolol Fumarate On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >CARVEDILOL Carvedilol Restricted 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >ESMOLOL HYDROCHLORIDE Brevibloc® Restricted 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >LABETALOL HYDROCHLORIDE Labetalol Hydrochloride On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >METOPROLOL TARTRATE Metoprolol Tartrate On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >PROPRANOLOL HYDROCHLORIDE Propranolol On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >PROPRANOLOL HYDROCHLORIDE->Modified release Half-Inderal LA® On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >PROPRANOLOL HYDROCHLORIDE->Modified release Inderal-LA® On Formulary 2 Cardiovascular system->2.4 Beta-adrenoceptor blocking drugs- >SOTALOL HYDROCHLORIDE Sotalol Restricted 2 Cardiovascular system->2.5 and failure->2.5.1 Vasodilator antihypertensive drugs HYDRALAZINE HYDROCHLORIDE On Formulary 2 Cardiovascular system->2.5 Hypertension and ->2.5.1 Vasodilator antihypertensive drugs DIAZOXIDE Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs MINOXIDIL Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs->DIAZOXIDE Eudemine® Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs->HYDRALAZINE HYDROCHLORIDE Hydralazine On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs->ILOPROST Ventavis® Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs->MINOXIDIL Loniten® Restricted

2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.1 Vasodilator antihypertensive drugs->SODIUM NITROPRUSSIDE Sodium Nitroprusside Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.2 Centrally acting antihypertensive drugs HYDROCHLORIDE On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.2 Centrally acting antihypertensive drugs On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.2 Centrally acting antihypertensive drugs MOXONIDINE Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.2 Centrally acting antihypertensive drugs->CLONIDINE HYDROCHLORIDE Catapres® On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.2 Centrally acting antihypertensive drugs->METHYLDOPA Methyldopa On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.2 Centrally acting antihypertensive drugs->MOXONIDINE Moxonidine Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.3 Adrenergic neurone blocking drugs GUANETHIDINE MONOSULFATE Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking drugs On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.4 Alpha-adrenoceptor blocking drugs->DOXAZOSIN Doxazosin On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Angiotensin- converting inhibitors LISINOPRIL On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Angiotensin- converting enzyme inhibitors PERINDOPRIL ERBUMINE On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Angiotensin- converting enzyme inhibitors RAMIPRIL On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Angiotensin- converting enzyme inhibitors CAPTOPRIL Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Angiotensin- converting enzyme inhibitors->CAPTOPRIL Captopril Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Angiotensin- converting enzyme inhibitors->LISINOPRIL Lisinopril On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.1 Angiotensin- converting enzyme inhibitors->RAMIPRIL Ramipril On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists LOSARTAN POTASSIUM On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists CANDESARTAN CILEXETIL Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists IRBESARTAN Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->CANDESARTAN CILEXETIL Amias® On Formulary 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->IRBESARTAN Aprovel® Restricted 2 Cardiovascular system->2.5 Hypertension and heart failure->2.5.5 Drugs affecting the renin-angiotensin system->2.5.5.2 Angiotensin-II receptor antagonists->LOSARTAN POTASSIUM Cozaar® Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 2 Cardiovascular system->2.6 Nitrates, -channel blockers, and other antianginal drugs->2.6.1 Nitrates GLYCERYL TRINITRATE On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.1 Nitrates ISOSORBIDE DINITRATE On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.1 Nitrates ISOSORBIDE MONONITRATE On Formulary

2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE Parenteral preparations Restricted 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE- >Short-acting tablets and sprays Glyceryl Trinitrate On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.1 Nitrates->GLYCERYL TRINITRATE- >Transdermal preparations Deponit® On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.1 Nitrates->ISOSORBIDE DINITRATE->Modified-release preparations Isoket Retard® On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.1 Nitrates->ISOSORBIDE DINITRATE->Short-acting tablets and sprays Isosorbide Dinitrate On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE Isosorbide Mononitrate On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.1 Nitrates->ISOSORBIDE MONONITRATE Modified release On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers AMLODIPINE On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers DILTIAZEM HYDROCHLORIDE On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers HYDROCHLORIDE On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers NIMODIPINE Restricted 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >AMLODIPINE Amlodipine On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >DILTIAZEM HYDROCHLORIDE Longer-acting formulations On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >DILTIAZEM HYDROCHLORIDE->Standard formulations Tildiem® On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >NIFEDIPINE Modified release On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >NIFEDIPINE Nifedipine On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >NIFEDIPINE->Modified release Adalat® LA On Formulary This formulary was published on 8th January 2014

Formulary Sec tion Title Status 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >NIFEDIPINE->Modified release Adalat® Retard On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >NIMODIPINE Nimotop® Restricted 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >VERAPAMIL HYDROCHLORIDE Modified release On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.2 Calcium-channel blockers- >VERAPAMIL HYDROCHLORIDE Verapamil On Formulary 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.3 Other antianginal drugs IVABRADINE NICE-approved 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.3 Other antianginal drugs NICORANDIL Restricted 2 Cardiovascular system->2.6 Nitrates, calcium-channel blockers, and other antianginal drugs->2.6.4 Peripheral vasodilators and related drugs NICE-approved 2 Cardiovascular system->2.7 Sympathomimetics->2.7.1 Inotropic sympathomimetics Restricted 2 Cardiovascular system->2.7 Sympathomimetics->2.7.1 Inotropic sympathomimetics HYDROCHLORIDE Restricted 2 Cardiovascular system->2.7 Sympathomimetics->2.7.1 Inotropic sympathomimetics->DOBUTAMINE Dobutamine Restricted 2 Cardiovascular system->2.7 Sympathomimetics->2.7.1 Inotropic sympathomimetics->DOPAMINE HYDROCHLORIDE Dopamine Restricted 2 Cardiovascular system->2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics Restricted

2 Cardiovascular system->2.7 Sympathomimetics->2.7.2 NORADRENALINE/NOREPINEPHRI Vasoconstrictor sympathomimetics NE Restricted

2 Cardiovascular system->2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics HYDROCHLORIDE Restricted 2 Cardiovascular system->2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics->METARAMINOL Metaraminol Restricted 2 Cardiovascular system->2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics- >NORADRENALINE/ Noradrenaline/Norepinephrine Restricted 2 Cardiovascular system->2.7 Sympathomimetics->2.7.2 Vasoconstrictor sympathomimetics->PHENYLEPHRINE HYDROCHLORIDE Phenylephrine Restricted 2 Cardiovascular system->2.7 Sympathomimetics->2.7.3 Cardiopulmonary resuscitation /EPINEPHRINE On Formulary

2 Cardiovascular system->2.7 Sympathomimetics->2.7.3 Adrenaline/Epinephrine 1 in Cardiopulmonary resuscitation->ADRENALINE/EPINEPHRINE 10?000, Dilute On Formulary 2 Cardiovascular system->2.8 and protamine->2.8.1 Parenteral anticoagulants On Formulary 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants Heparin flushes On Formulary 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants Low molecular weight On Formulary 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants Epoprostenol Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants Heparinoids Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants Hirudins Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants->Epoprostenol EPOPROSTENOL Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants->Epoprostenol->EPOPROSTENOL Flolan® Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants->Heparin HEPARIN On Formulary 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants->Heparin flushes Heparin Sodium On Formulary 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants->Heparinoids DANAPAROID SODIUM Restricted

2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants->Heparinoids->DANAPAROID SODIUM Orgaran® Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants->Hirudins BIVALIRUDIN Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants->Hirudins->BIVALIRUDIN Angiox® Restricted

2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.1 Parenteral anticoagulants->Low molecular weight heparins ENOXAPARIN SODIUM On Formulary 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Apixaban APIXABAN NICE-approved 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Apixaban APIXABAN NICE-approved 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Coumarins and phenindione SODIUM On Formulary 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Coumarins and phenindione ACENOCOUMAROL Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Coumarins and phenindione PHENINDIONE Restricted

2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Coumarins and phenindione->PHENINDIONE Phenindione Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Coumarins and phenindione->WARFARIN SODIUM Warfarin On Formulary 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Dabigatran etexilate DABIGATRAN ETEXILATE NICE-approved 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Dabigatran etexilate DABIGATRAN ETEXILATE NICE-approved 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Rivaroxaban RIVAROXABAN Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Rivaroxaban RIVAROXABAN Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Rivaroxaban RIVAROXABAN Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.2 Oral anticoagulants->Rivaroxaban RIVAROXABAN Restricted 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.3 Protamine sulfate PROTAMINE SULFATE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 2 Cardiovascular system->2.8 Anticoagulants and protamine->2.8.3 Protamine sulfate->PROTAMINE SULFATE Protamine Sulfate Restricted 2 Cardiovascular system->2.9 Antiplatelet drugs (antiplatelet) On Formulary 2 Cardiovascular system->2.9 Antiplatelet drugs ABCIXIMAB Restricted 2 Cardiovascular system->2.9 Antiplatelet drugs CLOPIDOGREL Restricted 2 Cardiovascular system->2.9 Antiplatelet drugs Restricted 2 Cardiovascular system->2.9 Antiplatelet drugs PRASUGREL Restricted 2 Cardiovascular system->2.9 Antiplatelet drugs TICAGRELOR Restricted 2 Cardiovascular system->2.9 Antiplatelet drugs TIROFIBAN Restricted 2 Cardiovascular system->2.9 Antiplatelet drugs->ASPIRIN (antiplatelet) Aspirin On Formulary 2 Cardiovascular system->2.9 Antiplatelet drugs->DIPYRIDAMOLE Dipyridamole Restricted 2 Cardiovascular system->2.9 Antiplatelet drugs->DIPYRIDAMOLE Modified release Restricted 2 Cardiovascular system->2.9 Antiplatelet drugs->DIPYRIDAMOLE- >Modified release Persantin® Retard Restricted 3 ->3.1 Bronchodilators->3.1.1 Adrenoceptor ->3.1.1.1 Selective beta2 agonists On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective beta2 agonists On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective beta2 agonists SULFATE Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective beta2 agonists->SALBUTAMOL- >Inhalation Salbutamol On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective beta2 agonists->SALBUTAMOL->Oral Salbutamol Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective beta2 agonists->SALBUTAMOL- >Parenteral Ventolin® On Formulary

3 Respiratory system->3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective beta2 agonists->TERBUTALINE SULFATE Inhalation Restricted

3 Respiratory system->3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.1 Selective beta2 agonists->TERBUTALINE SULFATE Oral and parenteral Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.1 Adrenoceptor agonists->3.1.1.2 Other adrenoceptor agonists HYDROCHLORIDE Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.2 Antimuscarinic bronchodilators IPRATROPIUM BROMIDE On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.2 Antimuscarinic bronchodilators GLYCOPYRRONIUM Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.2 Antimuscarinic bronchodilators TIOTROPIUM Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.2 Antimuscarinic bronchodilators->IPRATROPIUM BROMIDE Atrovent® On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.2 Antimuscarinic bronchodilators->IPRATROPIUM BROMIDE Ipratropium Bromide On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.3 Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.3 Theophylline THEOPHYLLINE Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.3 Theophylline- >AMINOPHYLLINE Aminophylline Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 3 Respiratory system->3.1 Bronchodilators->3.1.3 Theophylline- >AMINOPHYLLINE Modified release Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.3 Theophylline- >AMINOPHYLLINE->Modified release Phyllocontin Continus® Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.3 Theophylline- >THEOPHYLLINE Modified release Restricted 3 Respiratory system->3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers->Drug delivery devices Able Spacer® On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers->Drug delivery devices AeroChamber® Plus On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers->Drug delivery devices Haleraid® On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers->Drug delivery devices Volumatic® On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers->Nebuliser diluent Sodium Chloride On Formulary 3 Respiratory system->3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers->Peak flow meters Low Range Peak Flow Meter On Formulary

3 Respiratory system->3.1 Bronchodilators->3.1.5 Peak flow meters, inhaler devices and nebulisers->Peak flow meters Standard Range Peak Flow Meter On Formulary 3 Respiratory system->3.11 Antifibrotics PIRFENIDONE NICE-approved

3 Respiratory system->3.2 Corticosteroids DIPROPIONATE On Formulary 3 Respiratory system->3.2 Corticosteroids BUDESONIDE Restricted 3 Respiratory system->3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE Beclometasone On Formulary 3 Respiratory system->3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE Clenil Modulite® On Formulary 3 Respiratory system->3.2 Corticosteroids->BECLOMETASONE DIPROPIONATE->Compound preparations Fostair® On Formulary 3 Respiratory system->3.2 Corticosteroids->BUDESONIDE Budesonide Restricted 3 Respiratory system->3.2 Corticosteroids->BUDESONIDE Pulmicort® Restricted 3 Respiratory system->3.2 Corticosteroids->BUDESONIDE- >Compound preparations Symbicort® Restricted 3 Respiratory system->3.2 Corticosteroids->FLUTICASONE PROPIONATE->Compound preparations Seretide® Restricted 3 Respiratory system->3.3 Cromoglicate and related therapy, receptor antagonists, and phosphodiesterase type-4 inhibitors->3.3.2 Leukotriene receptor antagonists MONTELUKAST Restricted 3 Respiratory system->3.3 Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inhibitors->3.3.3 Phosphodiesterase type-4 inhibitors NICE-approved 3 Respiratory system->3.4 , hyposensitisation, and allergic emergencies->3.4.1 Antihistamines->Non-sedating antihistamines CETIRIZINE HYDROCHLORIDE On Formulary 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Antihistamines->Non-sedating antihistamines LORATADINE On Formulary 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Antihistamines->Non-sedating antihistamines->CETIRIZINE HYDROCHLORIDE Cetirizine On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Antihistamines->Non-sedating antihistamines->LORATADINE Loratadine On Formulary 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Antihistamines->Sedating antihistamines MALEATE On Formulary 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Antihistamines->Sedating antihistamines HYDROCHLORIDE On Formulary 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Antihistamines->Sedating antihistamines HYDROCHLORIDE On Formulary 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.1 Antihistamines->Sedating antihistamines->CHLORPHENAMINE MALEATE Chlorphenamine On Formulary

3 Respiratory system->3.4 Antihistamines, hyposensitisation, and BEE AND WASP ALLERGEN allergic emergencies->3.4.2 Allergen immunotherapy EXTRACTS On Formulary

3 Respiratory system->3.4 Antihistamines, hyposensitisation, and GRASS AND TREE POLLEN allergic emergencies->3.4.2 Allergen immunotherapy EXTRACTS On Formulary 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.2 Allergen immunotherapy->BEE AND WASP ALLERGEN EXTRACTS Pharmalgen® NICE-approved 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.2 Allergen immunotherapy->GRASS AND TREE POLLEN EXTRACTS Grass pollen extract Restricted 3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.2 Allergen immunotherapy->GRASS AND TREE POLLEN EXTRACTS->Grass pollen extract Grazax® Restricted

3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.2 Allergen immunotherapy->Omalizumab OMALIZUMAB NICE-approved

3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.3 Allergic emergencies->Anaphylaxis ADRENALINE/EPINEPHRINE On Formulary

3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.3 Allergic emergencies->Anaphylaxis- >ADRENALINE/EPINEPHRINE->Intramuscular or subcutaneous Adrenaline/Epinephrine 1 in 1000 On Formulary

3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.3 Allergic emergencies->Anaphylaxis- >ADRENALINE/EPINEPHRINE->Intramuscular or subcutaneous Minijet® Adrenaline 1 in 1000 On Formulary

3 Respiratory system->3.4 Antihistamines, hyposensitisation, and allergic emergencies->3.4.3 Allergic emergencies->Angioedema C1-ESTERASE INHIBITOR Restricted 3 Respiratory system->3.5 Respiratory stimulants and pulmonary surfactants->3.5.1 Respiratory stimulants DOXAPRAM HYDROCHLORIDE Restricted 3 Respiratory system->3.5 Respiratory stimulants and pulmonary surfactants->3.5.1 Respiratory stimulants->DOXAPRAM HYDROCHLORIDE Dopram® Restricted 3 Respiratory system->3.5 Respiratory stimulants and pulmonary surfactants->3.5.2 Pulmonary surfactants PORACTANT ALFA Restricted 3 Respiratory system->3.7 Mucolytics CARBOCISTEINE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 3 Respiratory system->3.7 Mucolytics Dornase alfa Restricted 3 Respiratory system->3.7 Mucolytics->CARBOCISTEINE Carbocisteine Restricted 3 Respiratory system->3.7 Mucolytics->Dornase alfa DORNASE ALFA Restricted 3 Respiratory system->3.7 Mucolytics->Mannitol MANNITOL NICE-approved

3 Respiratory system->3.8 Aromatic inhalations Benzoin Tincture, Compound, BP On Formulary 3 Respiratory system->3.9 Cough preparations->3.9.1 Cough suppressants PHOLCODINE On Formulary 3 Respiratory system->3.9 Cough preparations->3.9.1 Cough suppressants CODEINE PHOSPHATE Restricted 3 Respiratory system->3.9 Cough preparations->3.9.1 Cough suppressants->CODEINE PHOSPHATE Codeine Linctus, BP On Formulary 3 Respiratory system->3.9 Cough preparations->3.9.1 Cough suppressants->Palliative care MORPHINE HYDROCHLORIDE On Formulary 3 Respiratory system->3.9 Cough preparations->3.9.1 Cough suppressants->Palliative care METHADONE HYDROCHLORIDE Restricted 3 Respiratory system->3.9 Cough preparations->3.9.1 Cough suppressants->PHOLCODINE Pholcodine Linctus, BP On Formulary 3 Respiratory system->3.9 Cough preparations->3.9.2 Demulcent and expectorant cough preparations Simple Linctus, BP On Formulary 3 Respiratory system->3.9 Cough preparations->3.9.2 Demulcent and expectorant cough preparations Simple Linctus, Paediatric, BP On Formulary

4 ->4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Antihistamines PROMETHAZINE HYDROCHLORIDE On Formulary 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Benzodiazepines TEMAZEPAM On Formulary 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Benzodiazepines->TEMAZEPAM Temazepam On Formulary 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Chloral and derivatives CHLORAL HYDRATE Restricted 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Chloral and derivatives->CHLORAL HYDRATE Chloral Mixture, BP 2000 Restricted 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Zaleplon, , and ZOPICLONE On Formulary 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.1 Hypnotics->Zaleplon, zolpidem, and zopiclone->ZOPICLONE Zopiclone On Formulary 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.2 Anxiolytics->Benzodiazepines On Formulary 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.2 Anxiolytics->Benzodiazepines LORAZEPAM On Formulary 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.2 Anxiolytics->Benzodiazepines->DIAZEPAM Diazepam On Formulary 4 Central nervous system->4.1 Hypnotics and anxiolytics->4.1.2 Anxiolytics->Benzodiazepines->LORAZEPAM Lorazepam On Formulary 4 Central nervous system->4.10 Drugs used in substance dependence->4.10.1 dependence->Acamprosate ACAMPROSATE CALCIUM Restricted 4 Central nervous system->4.10 Drugs used in substance dependence->4.10.2 Nicotine dependence->Bupropion HYDROCHLORIDE On Formulary 4 Central nervous system->4.10 Drugs used in substance dependence->4.10.2 Nicotine dependence->Nicotine replacement therapy NICOTINE On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 4 Central nervous system->4.10 Drugs used in substance dependence->4.10.2 Nicotine dependence->Nicotine replacement therapy->NICOTINE NiQuitin® On Formulary 4 Central nervous system->4.10 Drugs used in substance dependence->4.10.2 Nicotine dependence->Varenicline VARENICLINE Restricted 4 Central nervous system->4.10 Drugs used in substance dependence->4.10.3 dependence->Opioid substitution therapy BUPRENORPHINE Restricted 4 Central nervous system->4.10 Drugs used in substance dependence->4.10.3 Opioid dependence->Opioid substitution therapy METHADONE HYDROCHLORIDE Restricted 4 Central nervous system->4.10 Drugs used in substance dependence->4.10.3 Opioid dependence->Opioid substitution therapy->METHADONE HYDROCHLORIDE Methadone Restricted 4 Central nervous system->4.10 Drugs used in substance dependence->4.10.3 Opioid dependence->Opioid-receptor antagonists NALTREXONE HYDROCHLORIDE NICE-approved 4 Central nervous system->4.11 Drugs for dementia NICE-approved 4 Central nervous system->4.11 Drugs for dementia HYDROCHLORIDE NICE-approved 4 Central nervous system->4.11 Drugs for dementia RIVASTIGMINE NICE-approved 4 Central nervous system->4.11 Drugs for dementia DONEPEZIL HYDROCHLORIDE Restricted 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 drugs->First-generation antipsychotic drugs HYDROCHLORIDE On Formulary 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs On Formulary 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs On Formulary 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs HYDROCHLORIDE On Formulary 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs On Formulary 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs Restricted 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs Restricted 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs->CHLORPROMAZINE HYDROCHLORIDE Chlorpromazine On Formulary 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs->HALOPERIDOL Haloperidol On Formulary 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs->PROMAZINE HYDROCHLORIDE Promazine On Formulary 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->First-generation antipsychotic drugs->TRIFLUOPERAZINE Trifluoperazine On Formulary This formulary was published on 8th January 2014

Formulary Sec tion Title Status 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->Second-generation antipsychotic drugs Restricted 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->Second-generation antipsychotic drugs Restricted 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->Second-generation antipsychotic drugs Restricted Senior 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->Second-generation pharmacist antipsychotic drugs approval Senior 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->Second-generation pharmacist antipsychotic drugs approval Senior 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->Second-generation pharmacist antipsychotic drugs approval Senior 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.1 Antipsychotic drugs->Second-generation pharmacist antipsychotic drugs->AMISULPRIDE Amisulpride approval 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.2 Antipsychotic depot injections HALOPERIDOL Restricted Senior 4 Central nervous system->4.2 Drugs used in psychoses and related pharmacist disorders->4.2.2 Antipsychotic depot injections FLUPENTIXOL DECANOATE approval Senior 4 Central nervous system->4.2 Drugs used in psychoses and related pharmacist disorders->4.2.2 Antipsychotic depot injections DECANOATE approval Senior 4 Central nervous system->4.2 Drugs used in psychoses and related pharmacist disorders->4.2.2 Antipsychotic depot injections RISPERIDONE approval 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.2 Antipsychotic depot injections->FLUPHENAZINE DECANOATE Fluphenazine decanoate Restricted

4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.2 Antipsychotic depot injections->HALOPERIDOL Haldol Decanoate® Restricted

4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.2 Antipsychotic depot injections->RISPERIDONE Risperdal Consta® Restricted 4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.3 Drugs used for mania and hypomania Carbamazepine Restricted Senior 4 Central nervous system->4.2 Drugs used in psychoses and related pharmacist disorders->4.2.3 Drugs used for mania and hypomania approval Senior 4 Central nervous system->4.2 Drugs used in psychoses and related pharmacist disorders->4.2.3 Drugs used for mania and hypomania approval This formulary was published on 8th January 2014

Formulary Sec tion Title Status

4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.3 Drugs used for mania and hypomania->Lithium Restricted

4 Central nervous system->4.2 Drugs used in psychoses and related disorders->4.2.3 Drugs used for mania and hypomania->Lithium LITHIUM CITRATE Restricted

4 Central nervous system->4.3 drugs->4.3.1 Tricyclic and related antidepressant drugs->Tricyclic HYDROCHLORIDE On Formulary Senior 4 Central nervous system->4.3 Antidepressant drugs->4.3.1 Tricyclic pharmacist and related antidepressant drugs->Tricyclic antidepressants HYDROCHLORIDE approval Senior 4 Central nervous system->4.3 Antidepressant drugs->4.3.1 Tricyclic pharmacist and related antidepressant drugs->Tricyclic antidepressants approval 4 Central nervous system->4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant drugs->Tricyclic antidepressants- >AMITRIPTYLINE HYDROCHLORIDE Amitriptyline On Formulary 4 Central nervous system->4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant drugs->Tricyclic antidepressants- >CLOMIPRAMINE HYDROCHLORIDE Clomipramine Restricted

4 Central nervous system->4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant drugs->Tricyclic-related antidepressants HYDROCHLORIDE On Formulary 4 Central nervous system->4.3 Antidepressant drugs->4.3.1 Tricyclic and related antidepressant drugs->Tricyclic-related antidepressants- >TRAZODONE HYDROCHLORIDE Trazodone On Formulary 4 Central nervous system->4.3 Antidepressant drugs->4.3.3 Selective re-uptake inhibitors CITALOPRAM On Formulary 4 Central nervous system->4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake inhibitors On Formulary Senior 4 Central nervous system->4.3 Antidepressant drugs->4.3.3 pharmacist Selective serotonin re-uptake inhibitors approval Senior 4 Central nervous system->4.3 Antidepressant drugs->4.3.3 pharmacist Selective serotonin re-uptake inhibitors SERTRALINE approval 4 Central nervous system->4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake inhibitors->CITALOPRAM Citalopram On Formulary 4 Central nervous system->4.3 Antidepressant drugs->4.3.3 Selective serotonin re-uptake inhibitors->FLUOXETINE Fluoxetine On Formulary Senior 4 Central nervous system->4.3 Antidepressant drugs->4.3.3 pharmacist Selective serotonin re-uptake inhibitors->PAROXETINE Paroxetine approval 4 Central nervous system->4.3 Antidepressant drugs->4.3.4 Other antidepressant drugs DULOXETINE Restricted 4 Central nervous system->4.3 Antidepressant drugs->4.3.4 Other antidepressant drugs FLUPENTIXOL Restricted 4 Central nervous system->4.3 Antidepressant drugs->4.3.4 Other antidepressant drugs Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status Senior 4 Central nervous system->4.3 Antidepressant drugs->4.3.4 Other pharmacist antidepressant drugs VENLAFAXINE approval 4 Central nervous system->4.3 Antidepressant drugs->4.3.4 Other antidepressant drugs->VENLAFAXINE Modified release Restricted

4 Central nervous system->4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder HYDROCHLORIDE Restricted 4 Central nervous system->4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder->METHYLPHENIDATE HYDROCHLORIDE Methylphenidate Hydrochloride Restricted 4 Central nervous system->4.4 CNS stimulants and drugs used for attention deficit hyperactivity disorder->METHYLPHENIDATE HYDROCHLORIDE Modified release Restricted 4 Central nervous system->4.5 Drugs used in the treatment of obesity->4.5.1 Anti-obesity drugs acting on the gastro-intestinal tract Restricted 4 Central nervous system->4.6 Drugs used in and - >5HT3-receptor antagonists Restricted 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Antihistamines CINNARIZINE On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Antihistamines On Formulary

4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Antihistamines PROMETHAZINE HYDROCHLORIDE On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Antihistamines->CINNARIZINE Cinnarizine On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Domperidone and On Formulary

4 Central nervous system->4.6 Drugs used in nausea and vertigo- METOCLOPRAMIDE >Domperidone and metoclopramide HYDROCHLORIDE On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Domperidone and metoclopramide->DOMPERIDONE Domperidone On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Domperidone and metoclopramide->METOCLOPRAMIDE HYDROCHLORIDE Metoclopramide On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Hyoscine HYOSCINE HYDROBROMIDE On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Hyoscine->HYOSCINE HYDROBROMIDE Patches On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Neurokinin-receptor antagonists APREPITANT Restricted

4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Other drugs for Ménière's disease BETAHISTINE DIHYDROCHLORIDE On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Other drugs for Ménière's disease->BETAHISTINE DIHYDROCHLORIDE Betahistine Dihydrochloride On Formulary

4 Central nervous system->4.6 Drugs used in nausea and vertigo- CHLORPROMAZINE >Phenothiazines and related drugs HYDROCHLORIDE On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Phenothiazines and related drugs PROCHLORPERAZINE On Formulary 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Phenothiazines and related drugs TRIFLUOPERAZINE On Formulary This formulary was published on 8th January 2014

Formulary Sec tion Title Status 4 Central nervous system->4.6 Drugs used in nausea and vertigo- >Phenothiazines and related drugs->PROCHLORPERAZINE Prochlorperazine On Formulary 4 Central nervous system->4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic preparations ASPIRIN On Formulary 4 Central nervous system->4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic preparations CO-CODAMOL On Formulary 4 Central nervous system->4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic preparations CO-DYDRAMOL On Formulary 4 Central nervous system->4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic preparations On Formulary

4 Central nervous system->4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic preparations Compound analgesic preparations Restricted 4 Central nervous system->4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic preparations->ASPIRIN Aspirin On Formulary

4 Central nervous system->4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic preparations->CO-CODAMOL With codeine phosphate 30?mg On Formulary

4 Central nervous system->4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic preparations->PARACETAMOL Paracetamol On Formulary

4 Central nervous system->4.7 Analgesics->4.7.1 Non-opioid analgesics and compound analgesic preparations->PARACETAMOL Perfalgan® Restricted

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics DIAMORPHINE HYDROCHLORIDE On Formulary

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics DIHYDROCODEINE TARTRATE On Formulary

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics MORPHINE SALTS On Formulary

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics PETHIDINE HYDROCHLORIDE On Formulary

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics BUPRENORPHINE Restricted

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics CODEINE PHOSPHATE Restricted

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics FENTANYL Restricted

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics Restricted

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics HYDROCHLORIDE Restricted 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >CODEINE PHOSPHATE Codeine Phosphate Restricted 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >DIAMORPHINE HYDROCHLORIDE Diamorphine On Formulary 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >DIHYDROCODEINE TARTRATE Dihydrocodeine On Formulary 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >FENTANYL Patches Restricted 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >FENTANYL->Patches Durogesic DTrans® Restricted 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >METHADONE HYDROCHLORIDE Methadone Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >MORPHINE SALTS->Injections Morphine Sulfate On Formulary

4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >MORPHINE SALTS->Modified-release 12-hourly oral preparations Zomorph® On Formulary 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >MORPHINE SALTS->Oral Morphine Oral Solutions On Formulary 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >MORPHINE SALTS->Oral solutions Oramorph® On Formulary 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >MORPHINE SALTS->Suppositories Morphine On Formulary 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >MORPHINE SALTS->Tablets Sevredol® On Formulary 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >PAPAVERETUM Papaveretum Restricted 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >PETHIDINE HYDROCHLORIDE Pethidine On Formulary 4 Central nervous system->4.7 Analgesics->4.7.2 Opioid analgesics- >TRAMADOL HYDROCHLORIDE Tramadol Hydrochloride Restricted

4 Central nervous system->4.7 Analgesics->4.7.4 Antimigraine drugs- >4.7.4.1 Treatment of acute ->5HT1-receptor agonists On Formulary 4 Central nervous system->4.7 Analgesics->4.7.4 Antimigraine drugs- >4.7.4.2 Prophylaxis of migraine On Formulary 4 Central nervous system->4.7 Analgesics->4.7.4 Antimigraine drugs- >4.7.4.2 Prophylaxis of migraine->PIZOTIFEN Pizotifen On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Benzodiazepines CLOBAZAM Restricted 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Benzodiazepines CLONAZEPAM Restricted 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Carbamazepine and related antiepileptics CARBAMAZEPINE On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Carbamazepine and related antiepileptics OXCARBAZEPINE Restricted 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Carbamazepine and related antiepileptics- >CARBAMAZEPINE Carbamazepine On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Gabapentin and pregabalin GABAPENTIN On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Gabapentin and pregabalin PREGABALIN Restricted 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Gabapentin and pregabalin->GABAPENTIN Gabapentin On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Lamotrigine On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Lamotrigine->LAMOTRIGINE Lamotrigine On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Levetiracetam LEVETIRACETAM Restricted 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Phenobarbital and primidone PHENOBARBITAL On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Phenobarbital and primidone PRIMIDONE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Phenobarbital and primidone->PHENOBARBITAL Phenobarbital On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Phenytoin On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Phenytoin->PHENYTOIN Phenytoin On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Retigabine RETIGABINE NICE-approved 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Topiramate TOPIRAMATE Restricted 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Valproate SODIUM VALPROATE On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Valproate->SODIUM VALPROATE->Oral Sodium Valproate On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.1 Control of the epilepsies->Vigabatrin VIGABATRIN Restricted 4 Central nervous system->4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus DIAZEPAM On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus LORAZEPAM On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus PHENOBARBITAL SODIUM On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus PHENYTOIN SODIUM On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus CLONAZEPAM Restricted 4 Central nervous system->4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus MIDAZOLAM Restricted 4 Central nervous system->4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus->DIAZEPAM Diazepam On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus->PHENOBARBITAL SODIUM Phenobarbital On Formulary 4 Central nervous system->4.8 Antiepileptic drugs->4.8.2 Drugs used in status epilepticus->PHENYTOIN SODIUM Phenytoin On Formulary 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Catechol-O-methyltransferase inhibitors ENTACAPONE Restricted 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor agonists HYDROCHLORIDE Restricted 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor agonists Restricted 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor agonists Restricted 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor agonists Restricted 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor agonists Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor agonists Restricted 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Dopamine-receptor agonists->PERGOLIDE Pergolide Restricted 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Levodopa CO-BENELDOPA On Formulary 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Levodopa CO-CARELDOPA On Formulary 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Monoamine-oxidase-B inhibitors SELEGILINE HYDROCHLORIDE On Formulary 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Monoamine-oxidase-B inhibitors RASAGILINE Restricted 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.1 Dopaminergic drugs used in Parkinson's disease->Monoamine-oxidase-B inhibitors->SELEGILINE HYDROCHLORIDE Selegiline Hydrochloride On Formulary

4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.2 Antimuscarinic drugs used in parkinsonism HYDROCHLORIDE On Formulary

4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.2 Antimuscarinic drugs used in parkinsonism HYDROCHLORIDE On Formulary 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.2 Antimuscarinic drugs used in parkinsonism- >ORPHENADRINE HYDROCHLORIDE Orphenadrine Hydrochloride On Formulary 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.2 Antimuscarinic drugs used in parkinsonism- >PROCYCLIDINE HYDROCHLORIDE Procyclidine On Formulary 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.3 Drugs used in essential tremor, chorea, tics, and related disorders TETRABENAZINE Restricted 4 Central nervous system->4.9 Drugs used in parkinsonism and related disorders->4.9.3 Drugs used in essential tremor, chorea, tics, and related disorders->Torsion dystonias and other involuntary movements BOTULINUM TOXIN TYPE A Restricted 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and phenoxymethylpenicillin BENZYLPENICILLIN SODIUM On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and phenoxymethylpenicillin PHENOXYMETHYLPENICILLIN On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.1 Benzylpenicillin and phenoxymethylpenicillin- >PHENOXYMETHYLPENICILLIN Phenoxymethylpenicillin On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.2 Penicillinase-resistant penicillins FLUCLOXACILLIN On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.2 Penicillinase-resistant penicillins->FLUCLOXACILLIN Flucloxacillin On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins CO-AMOXICLAV On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins->AMOXICILLIN Amoxicillin On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.3 Broad-spectrum penicillins->CO-AMOXICLAV Co-amoxiclav Restricted

5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.4 Antipseudomonal penicillins PIPERACILLIN WITH TAZOBACTAM Restricted 5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.4 Antipseudomonal penicillins->PIPERACILLIN WITH TAZOBACTAM Piperacillin with tazobactam Restricted

5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.4 Antipseudomonal penicillins->TICARCILLIN WITH CLAVULANIC ACID Timentin Restricted

5 Infections->5.1 Antibacterial drugs->5.1.1 Penicillins->5.1.1.5 Mecillinams PIVMECILLINAM HYDROCHLORIDE Restricted 5 Infections->5.1 Antibacterial drugs->5.1.10 Antileprotic drugs DAPSONE Restricted 5 Infections->5.1 Antibacterial drugs->5.1.10 Antileprotic drugs- >DAPSONE Dapsone Restricted 5 Infections->5.1 Antibacterial drugs->5.1.11 Metronidazole and tinidazole METRONIDAZOLE On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.11 Metronidazole and tinidazole->METRONIDAZOLE Metronidazole On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.12 Quinolones CIPROFLOXACIN On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.12 Quinolones LEVOFLOXACIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.12 Quinolones MOXIFLOXACIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.12 Quinolones- >CIPROFLOXACIN Ciprofloxacin On Formulary

5 Infections->5.1 Antibacterial drugs->5.1.13 Urinary-tract infections NITROFURANTOIN On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.13 Urinary-tract infections->NITROFURANTOIN Nitrofurantoin On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.1 Cephalosporins CEFALEXIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.1 Cephalosporins CEFIXIME Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.1 Cephalosporins CEFOTAXIME Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.1 Cephalosporins CEFPODOXIME Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.1 Cephalosporins CEFTAZIDIME Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.1 Cephalosporins CEFTRIAXONE Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.1 Cephalosporins Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.1 Cephalosporins- >CEFALEXIN Cefalexin Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.2 Carbapenems ERTAPENEM Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.2 Carbapenems IMIPENEM WITH CILASTATIN Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.2 Carbapenems MEROPENEM Restricted 5 Infections->5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams->5.1.2.2 Carbapenems- >MEROPENEM Meropenem Restricted 5 Infections->5.1 Antibacterial drugs->5.1.3 Tetracyclines DOXYCYCLINE On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.3 Tetracyclines OXYTETRACYCLINE On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.3 Tetracyclines HYDROCHLORIDE Restricted 5 Infections->5.1 Antibacterial drugs->5.1.3 Tetracyclines MINOCYCLINE Restricted 5 Infections->5.1 Antibacterial drugs->5.1.3 Tetracyclines- >DOXYCYCLINE Doxycycline On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.3 Tetracyclines- >MINOCYCLINE Minocycline Restricted 5 Infections->5.1 Antibacterial drugs->5.1.3 Tetracyclines- >OXYTETRACYCLINE Oxytetracycline On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.4 Aminoglycosides GENTAMICIN On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.4 Aminoglycosides AMIKACIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.4 Aminoglycosides NEOMYCIN SULFATE Restricted 5 Infections->5.1 Antibacterial drugs->5.1.4 Aminoglycosides TOBRAMYCIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.4 Aminoglycosides- >AMIKACIN Amikacin Restricted 5 Infections->5.1 Antibacterial drugs->5.1.4 Aminoglycosides- >GENTAMICIN Gentamicin On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.4 Aminoglycosides- >NEOMYCIN SULFATE Neomycin Restricted 5 Infections->5.1 Antibacterial drugs->5.1.4 Aminoglycosides- >TOBRAMYCIN->Parenteral Tobramycin Restricted 5 Infections->5.1 Antibacterial drugs->5.1.5 Macrolides CLARITHROMYCIN On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.5 Macrolides AZITHROMYCIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.5 Macrolides ERYTHROMYCIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.5 Macrolides- >CLARITHROMYCIN Clarithromycin On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.5 Macrolides- >CLARITHROMYCIN Modified release On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.5 Macrolides- >CLARITHROMYCIN->Modified release Klaricid XL® On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.5 Macrolides- >ERYTHROMYCIN Erythromycin Restricted 5 Infections->5.1 Antibacterial drugs->5.1.5 Macrolides- >ERYTHROMYCIN Erythromycin Ethyl Succinate Restricted 5 Infections->5.1 Antibacterial drugs->5.1.5 Macrolides- >ERYTHROMYCIN Erythromycin Lactobionate Restricted 5 Infections->5.1 Antibacterial drugs->5.1.6 Clindamycin CLINDAMYCIN On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.6 Clindamycin- >CLINDAMYCIN Clindamycin On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Chloramphenicol CHLORAMPHENICOL Restricted 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Chloramphenicol->CHLORAMPHENICOL Kemicetine® Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Daptomycin DAPTOMYCIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Fusidic acid SODIUM FUSIDATE On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Linezolid LINEZOLID Restricted 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Polymyxins COLISTIMETHATE SODIUM Restricted 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Polymyxins->COLISTIMETHATE SODIUM Colomycin® Restricted 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Vancomycin and teicoplanin VANCOMYCIN On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Vancomycin and teicoplanin TEICOPLANIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.7 Some other antibacterials->Vancomycin and teicoplanin->VANCOMYCIN Vancomycin Restricted 5 Infections->5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim TRIMETHOPRIM On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim CO-TRIMOXAZOLE Restricted 5 Infections->5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim->CO-TRIMOXAZOLE Co-trimoxazole Restricted 5 Infections->5.1 Antibacterial drugs->5.1.8 Sulfonamides and trimethoprim->TRIMETHOPRIM Trimethoprim On Formulary

5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs ETHAMBUTOL HYDROCHLORIDE On Formulary

5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs On Formulary

5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs RIFAMPICIN On Formulary

5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs RIFAMPICIN WITH ISONIAZID On Formulary

5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs PYRAZINAMIDE Restricted

5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs RIFABUTIN Restricted 5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs- >ETHAMBUTOL HYDROCHLORIDE Ethambutol On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs- >ISONIAZID Isoniazid On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs- >RIFAMPICIN Rifampicin On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs- >RIFAMPICIN->Combined preparations Rifater® On Formulary 5 Infections->5.1 Antibacterial drugs->5.1.9 Antituberculosis drugs- >RIFAMPICIN->Combined preparations Voractiv® On Formulary 5 Infections->5.2 Antifungal drugs->5.2.1 Triazole antifungals FLUCONAZOLE On Formulary 5 Infections->5.2 Antifungal drugs->5.2.1 Triazole antifungals Restricted 5 Infections->5.2 Antifungal drugs->5.2.1 Triazole antifungals VORICONAZOLE Restricted 5 Infections->5.2 Antifungal drugs->5.2.1 Triazole antifungals- >FLUCONAZOLE Fluconazole On Formulary 5 Infections->5.2 Antifungal drugs->5.2.3 Polyene antifungals AMPHOTERICIN On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 5 Infections->5.2 Antifungal drugs->5.2.3 Polyene antifungals- >AMPHOTERICIN Fungizone® Restricted 5 Infections->5.2 Antifungal drugs->5.2.3 Polyene antifungals- >AMPHOTERICIN Lipid formulations Restricted 5 Infections->5.2 Antifungal drugs->5.2.3 Polyene antifungals- >AMPHOTERICIN->Lipid formulations AmBisome® Restricted

5 Infections->5.2 Antifungal drugs->5.2.4 Echinocandin antifungals CASPOFUNGIN Restricted 5 Infections->5.2 Antifungal drugs->5.2.5 Other antifungals GRISEOFULVIN Restricted 5 Infections->5.2 Antifungal drugs->5.2.5 Other antifungals TERBINAFINE Restricted 5 Infections->5.2 Antifungal drugs->5.2.5 Other antifungals- >GRISEOFULVIN Griseofulvin Restricted 5 Infections->5.2 Antifungal drugs->5.2.5 Other antifungals- >TERBINAFINE Terbinafine Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Non- nucleoside reverse transcriptase inhibitors Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Non- nucleoside reverse transcriptase inhibitors NEVIRAPINE Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors DIDANOSINE Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors EMTRICITABINE Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors STAVUDINE Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors TENOFOVIR DISOPROXIL Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors->ABACAVIR->With lamivudine and zidovudine Trizivir® Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors->EMTRICITABINE Emtriva® Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors->TENOFOVIR DISOPROXIL->With emtricitabine Truvada® Restricted

5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Nucleoside reverse transcriptase inhibitors->ZIDOVUDINE->With lamivudine Combivir® Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Other antiretrovirals ENFUVIRTIDE Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Other antiretrovirals MARAVIROC Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Other antiretrovirals RALTEGRAVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors ATAZANAVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors DARUNAVIR Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors FOSAMPRENAVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors LOPINAVIR WITH RITONAVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors RITONAVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors TIPRANAVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.1 HIV infection->Protease inhibitors->LOPINAVIR WITH RITONAVIR Kaletra® Restricted 5 Infections->5.3 Antiviral drugs->5.3.2 Herpesvirus infections- >5.3.2.1 Herpes simplex and varicella?zoster infection On Formulary 5 Infections->5.3 Antiviral drugs->5.3.2 Herpesvirus infections- >5.3.2.1 Herpes simplex and varicella?zoster infection Restricted

5 Infections->5.3 Antiviral drugs->5.3.2 Herpesvirus infections- >5.3.2.1 Herpes simplex and varicella?zoster infection->ACICLOVIR Aciclovir On Formulary 5 Infections->5.3 Antiviral drugs->5.3.2 Herpesvirus infections- >5.3.2.2 Cytomegalovirus infection FOSCARNET SODIUM Restricted 5 Infections->5.3 Antiviral drugs->5.3.2 Herpesvirus infections- >5.3.2.2 Cytomegalovirus infection GANCICLOVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.2 Herpesvirus infections- >5.3.2.2 Cytomegalovirus infection VALGANCICLOVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.3 Viral ->5.3.3.1 Chronic hepatitis B ADEFOVIR DIPIVOXIL Restricted 5 Infections->5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.1 Chronic hepatitis B ENTECAVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.2 Chronic hepatitis C TELAPREVIR NICE-approved 5 Infections->5.3 Antiviral drugs->5.3.3 Viral hepatitis->5.3.3.2 Chronic hepatitis C BOCEPREVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.4 Influenza OSELTAMIVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.4 Influenza OSELTAMIVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.4 Influenza Restricted 5 Infections->5.3 Antiviral drugs->5.3.4 Influenza ZANAMIVIR Restricted 5 Infections->5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus PALIVIZUMAB Restricted 5 Infections->5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus RIBAVIRIN Restricted 5 Infections->5.3 Antiviral drugs->5.3.5 Respiratory syncytial virus RIBAVIRIN Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials Mefloquine Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials Primaquine Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials Quinine Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials Tetracyclines Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials- >Chloroquine CHLOROQUINE On Formulary 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials- >Mefloquine MEFLOQUINE Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials- >Primaquine PRIMAQUINE Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials- >Primaquine->PRIMAQUINE Primaquine Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials- >Proguanil PROGUANIL HYDROCHLORIDE Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status

5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials- PROGUANIL HYDROCHLORIDE >Proguanil WITH ATOVAQUONE Restricted

5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials- PYRIMETHAMINE WITH >Pyrimethamine SULFADOXINE Restricted

5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Quinine QUININE On Formulary 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials->Quinine- >QUININE Quinine Sulfate On Formulary 5 Infections->5.4 Antiprotozoal drugs->5.4.1 Antimalarials- >Tetracyclines DOXYCYCLINE On Formulary 5 Infections->5.4 Antiprotozoal drugs->5.4.2 Amoebicides METRONIDAZOLE On Formulary 5 Infections->5.4 Antiprotozoal drugs->5.4.4 Antigiardial drugs MEPACRINE HYDROCHLORIDE Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.4 Antigiardial drugs- >MEPACRINE HYDROCHLORIDE Mepacrine Hydrochloride Restricted 5 Infections->5.4 Antiprotozoal drugs->5.4.8 Drugs for pneumocystis pneumonia PENTAMIDINE ISETIONATE Restricted

5 Infections->5.5 Anthelmintics Drugs for cutaneous larva migrans Restricted 5 Infections->5.5 Anthelmintics Drugs for strongyloidiasis Restricted 5 Infections->5.5 Anthelmintics Filaricides Restricted 5 Infections->5.5 Anthelmintics Schistosomicides Restricted 5 Infections->5.5 Anthelmintics->5.5.1 Drugs for threadworms MEBENDAZOLE On Formulary 5 Infections->5.5 Anthelmintics->5.5.1 Drugs for threadworms- >MEBENDAZOLE Mebendazole On Formulary 5 Infections->5.5 Anthelmintics->5.5.3 Drugs for tapeworm infections Hydatid disease Restricted 5 Infections->5.5 Anthelmintics->5.5.3 Drugs for tapeworm infections Taenicides Restricted 6 Endocrine system->6.1 Drugs used in diabetes Diabetic ketoacidosis Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.1 Short-acting insulins INSULIN GLULISINE On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.1 Short-acting insulins INSULIN ASPART Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.1 Short-acting insulins INSULIN LISPRO Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.1 Short-acting insulins->INSULIN GLULISINE Apidra® On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.1 Short-acting insulins->INSULIN LISPRO Humalog® Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.1 Short-acting insulins->INSULIN->Human sequence Actrapid® Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins INSULIN GLARGINE On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins ISOPHANE INSULIN On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins INSULIN DETEMIR Restricted

6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->Biphasic insulins BIPHASIC ISOPHANE INSULIN On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->Biphasic insulins BIPHASIC INSULIN LISPRO Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->Biphasic insulins- >BIPHASIC INSULIN LISPRO Humalog® Mix50 Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->Biphasic insulins- >BIPHASIC ISOPHANE INSULIN->Human sequence Insuman® Comb 15 On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->Biphasic insulins- >BIPHASIC ISOPHANE INSULIN->Human sequence Insuman® Comb 25 On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->Biphasic insulins- >BIPHASIC ISOPHANE INSULIN->Human sequence Insuman® Comb 50 On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->Biphasic insulins- >BIPHASIC ISOPHANE INSULIN->Human sequence Humulin M3® Restricted

6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->INSULIN GLARGINE Lantus® On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->ISOPHANE INSULIN- >Human sequence Insuman® Basal On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->ISOPHANE INSULIN- >Human sequence Humulin I® Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.1 Insulins- >6.1.1.2 Intermediate- and long-acting insulins->ISOPHANE INSULIN- >Human sequence Insulatard® Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 Sulfonylureas GLICLAZIDE On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 Sulfonylureas Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 Sulfonylureas TOLBUTAMIDE Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 Sulfonylureas->GLICLAZIDE Gliclazide On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.1 Sulfonylureas->TOLBUTAMIDE Tolbutamide Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.2 Biguanides METFORMIN HYDROCHLORIDE On Formulary

6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.2 Biguanides->METFORMIN HYDROCHLORIDE Metformin On Formulary

6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.2 Biguanides->METFORMIN HYDROCHLORIDE Modified release Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other antidiabetic drugs DAPAGLIFLOZIN NICE-approved 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other antidiabetic drugs LIRAGLUTIDE NICE-approved 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other antidiabetic drugs EXENATIDE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other antidiabetic drugs LINAGLIPTIN Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other antidiabetic drugs PIOGLITAZONE Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other antidiabetic drugs REPAGLINIDE Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other antidiabetic drugs SITAGLIPTIN Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other antidiabetic drugs->EXENATIDE Modified release Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.2 Antidiabetic drugs->6.1.2.3 Other antidiabetic drugs->EXENATIDE->Modified release Bydureon® Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.4 Treatment of hypoglycaemia GLUCAGON On Formulary 6 Endocrine system->6.1 Drugs used in diabetes->6.1.4 Treatment of hypoglycaemia->Chronic hypoglycaemia DIAZOXIDE Restricted 6 Endocrine system->6.1 Drugs used in diabetes->6.1.4 Treatment of hypoglycaemia->GLUCAGON GlucaGen® HypoKit On Formulary 6 Endocrine system->6.2 Thyroid and antithyroid drugs->6.2.1 Thyroid hormones SODIUM On Formulary 6 Endocrine system->6.2 Thyroid and antithyroid drugs->6.2.1 Thyroid hormones LIOTHYRONINE SODIUM On Formulary 6 Endocrine system->6.2 Thyroid and antithyroid drugs->6.2.1 Thyroid hormones->LEVOTHYROXINE SODIUM Levothyroxine On Formulary 6 Endocrine system->6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid drugs CARBIMAZOLE On Formulary 6 Endocrine system->6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid drugs IODINE AND IODIDE On Formulary 6 Endocrine system->6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid drugs PROPYLTHIOURACIL On Formulary 6 Endocrine system->6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid drugs->IODINE AND IODIDE Aqueous Iodine Oral On Formulary 6 Endocrine system->6.2 Thyroid and antithyroid drugs->6.2.2 Antithyroid drugs->PROPYLTHIOURACIL Propylthiouracil On Formulary 6 Endocrine system->6.3 Corticosteroids->6.3.1 Replacement therapy ACETATE On Formulary 6 Endocrine system->6.3 Corticosteroids->6.3.2 therapy On Formulary 6 Endocrine system->6.3 Corticosteroids->6.3.2 Glucocorticoid therapy On Formulary 6 Endocrine system->6.3 Corticosteroids->6.3.2 Glucocorticoid therapy On Formulary 6 Endocrine system->6.3 Corticosteroids->6.3.2 Glucocorticoid therapy PREDNISOLONE On Formulary 6 Endocrine system->6.3 Corticosteroids->6.3.2 Glucocorticoid therapy On Formulary 6 Endocrine system->6.3 Corticosteroids->6.3.2 Glucocorticoid therapy Restricted 6 Endocrine system->6.3 Corticosteroids->6.3.2 Glucocorticoid therapy->DEXAMETHASONE Dexamethasone On Formulary 6 Endocrine system->6.3 Corticosteroids->6.3.2 Glucocorticoid therapy->PREDNISOLONE Prednisolone On Formulary 6 Endocrine system->6.4 Sex hormones Anabolic Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT Restricted 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT OESTROGENS FOR HRT Restricted 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT Restricted

6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT->Ethinylestradiol ETHINYLESTRADIOL Restricted 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT- >Ethinylestradiol->ETHINYLESTRADIOL Ethinylestradiol Restricted 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT Conjugated oestrogens only On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT with On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS Conjugated oestrogens with FOR HRT progestogen Restricted 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT Estradiol only Restricted 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT->Conjugated oestrogens only Premarin® On Formulary

6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT->Conjugated oestrogens with progestogen Prempak-C® Restricted 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT->Estradiol only Evorel® Restricted 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.1 Oestrogens and HRT->OESTROGENS FOR HRT->Estradiol with progestogen Climagest® On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.2 and MEDROXYPROGESTERONE receptor modulators ACETATE On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.2 Progestogens and progesterone receptor modulators On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.2 Progestogens and progesterone receptor modulators PROGESTERONE On Formulary

6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.2 Progestogens and progesterone receptor modulators->MEDROXYPROGESTERONE ACETATE Provera® On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.2 Progestogens and progesterone receptor modulators->NORETHISTERONE Norethisterone On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 6 Endocrine system->6.4 Sex hormones->6.4.1 Female sex hormones and their modulators->6.4.1.2 Progestogens and progesterone receptor modulators->PROGESTERONE Cyclogest® On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->Anti- acetate On Formulary

6 Endocrine system->6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->Anti-androgens->Cyproterone acetate On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->Anti-androgens->Cyproterone acetate- >CYPROTERONE ACETATE Cyproterone Acetate On Formulary

6 Endocrine system->6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->Anti-androgens->Dutasteride and finasteride FINASTERIDE On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->TESTOSTERONE AND ESTERS Intramuscular On Formulary

6 Endocrine system->6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->TESTOSTERONE AND ESTERS->Intramuscular Sustanon 250® On Formulary 6 Endocrine system->6.4 Sex hormones->6.4.2 Male sex hormones and antagonists->TESTOSTERONE AND ESTERS->Transdermal preparations Tostran® On Formulary 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anterior pituitary hormones- >Corticotrophins TETRACOSACTIDE On Formulary 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anterior pituitary hormones- >Corticotrophins->TETRACOSACTIDE Synacthen® On Formulary 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anterior pituitary hormones- >Corticotrophins->TETRACOSACTIDE Synacthen Depot® Restricted 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anterior pituitary hormones- >Gonadotrophins CHORIONIC GONADOTROPHIN On Formulary 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anterior pituitary hormones- HUMAN MENOPAUSAL >Gonadotrophins GONADOTROPHINS On Formulary 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anterior pituitary hormones- >Growth hormone SOMATROPIN NICE-approved 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anterior pituitary hormones- >Growth hormone SOMATROPIN NICE-approved 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anti-oestrogens CITRATE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Anti-oestrogens->CLOMIFENE CITRATE Clomifene Restricted 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens->Hypothalamic hormones GONADORELIN On Formulary 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 Posterior pituitary hormones and antagonists->Posterior pituitary hormones On Formulary 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 Posterior pituitary hormones and antagonists->Posterior pituitary hormones ACETATE Restricted 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 Posterior pituitary hormones and antagonists->Posterior pituitary hormones Restricted 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 Posterior pituitary hormones and antagonists->Posterior pituitary hormones->DESMOPRESSIN Desmopressin acetate On Formulary 6 Endocrine system->6.5 Hypothalamic and pituitary hormones and anti-oestrogens->6.5.2 Posterior pituitary hormones and antagonists->Posterior pituitary hormones->VASOPRESSIN Synthetic vasopressin Restricted

6 Endocrine system->6.6 Drugs affecting bone ->6.6.1 CALCITONIN Calcitonin and parathyroid hormone (SALMON)/SALCATONIN Restricted 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.1 Calcitonin and parathyroid hormone TERIPARATIDE Restricted 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Bisphosphonates ALENDRONIC ACID On Formulary 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Bisphosphonates ALENDRONIC ACID On Formulary 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Bisphosphonates DISODIUM PAMIDRONATE On Formulary 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Bisphosphonates SODIUM CLODRONATE On Formulary 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Bisphosphonates Restricted 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Bisphosphonates RISEDRONATE SODIUM Restricted 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Bisphosphonates RISEDRONATE SODIUM Restricted 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Bisphosphonates ZOLEDRONIC ACID Restricted 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Bisphosphonates->DISODIUM PAMIDRONATE Disodium pamidronate On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Denosumab DENOSUMAB NICE-approved 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Denosumab DENOSUMAB NICE-approved 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Strontium ranelate RANELATE Restricted 6 Endocrine system->6.6 Drugs affecting bone metabolism->6.6.2 Bisphosphonates and other drugs affecting bone metabolism- >Strontium ranelate STRONTIUM RANELATE Restricted 6 Endocrine system->6.7 Other endocrine drugs->6.7.1 and other dopaminergic drugs BROMOCRIPTINE Restricted 6 Endocrine system->6.7 Other endocrine drugs->6.7.1 Bromocriptine and other dopaminergic drugs CABERGOLINE Restricted 6 Endocrine system->6.7 Other endocrine drugs->6.7.2 Drugs affecting gonadotrophins Restricted 6 Endocrine system->6.7 Other endocrine drugs->6.7.2 Drugs affecting gonadotrophins Gonadorelin analogues Restricted 6 Endocrine system->6.7 Other endocrine drugs->6.7.2 Drugs affecting gonadotrophins->DANAZOL Danazol Restricted 6 Endocrine system->6.7 Other endocrine drugs->6.7.2 Drugs affecting gonadotrophins->Gonadorelin analogues Restricted 6 Endocrine system->6.7 Other endocrine drugs->6.7.2 Drugs affecting gonadotrophins->Gonadorelin analogues ACETATE Restricted 6 Endocrine system->6.7 Other endocrine drugs->6.7.2 Drugs affecting gonadotrophins->Gonadorelin analogues TRIPTORELIN Restricted

6 Endocrine system->6.7 Other endocrine drugs->6.7.3 METYRAPONE Restricted 7 , , and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 and oxytocics On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics DINOPROSTONE On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics MALEATE On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics- >DINOPROSTONE Propess® On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics- >ERGOMETRINE MALEATE Ergometrine On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics- >ERGOMETRINE MALEATE With oxytocin Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics- >ERGOMETRINE MALEATE->With oxytocin Syntometrine® Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics->GEMEPROST Gemeprost On Formulary

7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.1 Prostaglandins and oxytocics->OXYTOCIN With ergometrine Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.2 MIFEPRISTONE Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.3 Myometrial relaxants->Atosiban ATOSIBAN Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.1 Drugs used in obstetrics->7.1.3 Myometrial relaxants->Beta2 agonists TERBUTALINE SULFATE Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.2 Treatment of vaginal and vulval conditions->7.2.1 Preparations for vaginal and vulval changes->Topical HRT for vaginal atrophy- >OESTROGENS, TOPICAL Ortho-Gynest® On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.2 Treatment of vaginal and vulval conditions->7.2.1 Preparations for vaginal and vulval changes->Topical HRT for vaginal atrophy- >OESTROGENS, TOPICAL Ovestin® On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.2 Treatment of vaginal and vulval conditions->7.2.1 Preparations for vaginal and vulval changes->Topical HRT for vaginal atrophy- >OESTROGENS, TOPICAL Vagifem® On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.2 Treatment of vaginal and vulval conditions->7.2.2 Vaginal and vulval infections->Fungal infections->PREPARATIONS FOR VAGINAL AND VULVAL CANDIDIASIS Clotrimazole On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.2 Treatment of vaginal and vulval conditions->7.2.2 Vaginal and vulval infections->Other infections->PREPARATIONS FOR OTHER VAGINAL INFECTIONS Dalacin® On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.2 Treatment of vaginal and vulval conditions->7.2.2 Vaginal and vulval infections->Other infections->PREPARATIONS FOR OTHER VAGINAL INFECTIONS Zidoval® On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Marvelon® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Desogestrel Mercilon® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Yasmin® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Femodene® Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Logynon® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Levonorgestrel Microgynon 30® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Norethisterone Brevinor® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Norethisterone Norimin® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Oral (low and standard strength)->Ethinylestradiol with Norgestimate Cilest® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Transdermal (standard strength)->Ethinylestradiol with Norelgestromin Evra® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.1 Combined hormonal contraceptives- >COMBINED HORMONAL CONTRACEPTIVES->Vaginal (low strength)- >Ethinylestradiol with NuvaRing® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.1 Oral progestogen-only contraceptives->ORAL PROGESTOGEN-ONLY CONTRACEPTIVES Cerazette® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.1 Oral progestogen-only contraceptives->ORAL PROGESTOGEN-ONLY CONTRACEPTIVES Micronor® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.1 Oral progestogen-only contraceptives->ORAL PROGESTOGEN-ONLY CONTRACEPTIVES Noriday® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.2 Parenteral progestogen-only contraceptives->PARENTERAL PROGESTOGEN-ONLY CONTRACEPTIVES->Implants Nexplanon® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.2 Parenteral progestogen-only contraceptives->PARENTERAL PROGESTOGEN-ONLY CONTRACEPTIVES->Injectable preparations Depo-Provera® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.3 INTRA-UTERINE PROGESTOGEN- Intra-uterine progestogen-only device ONLY SYSTEM On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.2 Progestogen-only contraceptives->7.3.2.3 Intra-uterine progestogen-only device->INTRA-UTERINE PROGESTOGEN-ONLY SYSTEM Mirena® On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.3 Spermicidal contraceptives Gygel® Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.4 Contraceptive devices->Intra-uterine devices- >INTRA-UTERINE CONTRACEPTIVE DEVICES Nova-T® 380 On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.5 Emergency contraception->Hormonal methods LEVONORGESTREL On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.3 Contraceptives->7.3.5 Emergency contraception->Hormonal methods->LEVONORGESTREL Levonelle® 1500 On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary retention->Alpha- blockers HYDROCHLORIDE On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary retention->Alpha- blockers DOXAZOSIN On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary retention->Alpha- blockers HYDROCHLORIDE Restricted

7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary retention->Alpha- blockers->ALFUZOSIN HYDROCHLORIDE->Modified release Xatral® XL On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.1 Drugs for urinary retention- >Parasympathomimetics BETHANECHOL CHLORIDE On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary frequency, enuresis, and incontinence->Urinary incontinence NICE-approved 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary frequency, enuresis, and incontinence->Urinary incontinence HYDROCHLORIDE On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary frequency, enuresis, and incontinence->Urinary incontinence TARTRATE On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary frequency, enuresis, and incontinence->Urinary incontinence PROPIVERINE HYDROCHLORIDE Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary frequency, enuresis, and incontinence->Urinary incontinence SOLIFENACIN SUCCINATE Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary frequency, enuresis, and incontinence->Urinary incontinence->OXYBUTYNIN HYDROCHLORIDE Oxybutynin Hydrochloride On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary frequency, enuresis, and incontinence->Urinary incontinence->OXYBUTYNIN HYDROCHLORIDE Transdermal preparations Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.2 Drugs for urinary frequency, enuresis, and incontinence->Urinary incontinence->OXYBUTYNIN HYDROCHLORIDE->Transdermal preparations Kentera® Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.3 Drugs used in urological pain- >Alkalinisation of POTASSIUM CITRATE On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.3 Drugs used in urological pain- >Alkalinisation of urine SODIUM CITRATE On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.3 Drugs used in urological pain- >Alkalinisation of urine->POTASSIUM CITRATE Potassium Citrate Mixture BP On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and urological surgery->Maintenance of indwelling urinary catheters CATHETER PATENCY SOLUTIONS On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and urological surgery->Maintenance of indwelling urinary catheters->CATHETER PATENCY SOLUTIONS Chlorhexidine 0.02% On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and urological surgery->Maintenance of indwelling urinary catheters->CATHETER PATENCY SOLUTIONS Sodium chloride 0.9% On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and urological surgery->Urological surgery GLYCINE On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.4 Bladder instillations and urological surgery->Urological surgery->GLYCINE Glycine Irrigation Solution On Formulary 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for Alprostadil Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile dysfunction and Restricted

7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for Phosphodiesterase type-5 genito-urinary disorders->7.4.5 Drugs for erectile dysfunction inhibitors Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile dysfunction- >Alprostadil ALPROSTADIL Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile dysfunction- >Phosphodiesterase type-5 inhibitors Restricted 7 Obstetrics, gynaecology, and urinary-tract disorders->7.4 Drugs for genito-urinary disorders->7.4.5 Drugs for erectile dysfunction- >Phosphodiesterase type-5 inhibitors->SILDENAFIL Viagra® Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs HYDROCHLORIDE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs PHOSPHATE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs->CYCLOPHOSPHAMIDE Cyclophosphamide Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs->LOMUSTINE Lomustine Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.1 Alkylating drugs->TREOSULFAN Treosulfan Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 and other cytotoxic antibiotics Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics HYDROCHLORIDE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics HYDROCHLORIDE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics HYDROCHLORIDE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics MITOMYCIN Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics->BLEOMYCIN Bleomycin Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics- >DAUNORUBICIN Daunorubicin Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics- >DOXORUBICIN HYDROCHLORIDE Lipid formulation Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics- >DOXORUBICIN HYDROCHLORIDE->Lipid formulation Myocet® Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics->MITOMYCIN Kyowa® Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.2 Anthracyclines and other cytotoxic antibiotics- >MITOXANTRONE Mitoxantrone Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites CAPECITABINE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites CAPECITABINE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites CAPECITABINE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites CAPECITABINE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites PHOSPHATE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites FLUDARABINE PHOSPHATE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites GEMCITABINE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites PEMETREXED Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites PEMETREXED Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites PEMETREXED Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites->CYTARABINE Cytarabine Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites->FLUOROURACIL Fluorouracil Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.3 Antimetabolites->METHOTREXATE Methotrexate Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.4 Vinca and ETOPOSIDE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.4 Vinca alkaloids and etoposide SULFATE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.4 Vinca alkaloids and etoposide SULFATE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.4 Vinca alkaloids and etoposide Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.4 Vinca alkaloids and etoposide->ETOPOSIDE Etoposide Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.4 Vinca alkaloids and etoposide->VINBLASTINE SULFATE Vinblastine Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.4 Vinca alkaloids and etoposide->VINCRISTINE SULFATE Vincristine Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bevacizumab BEVACIZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bevacizumab BEVACIZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bevacizumab BEVACIZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bevacizumab BEVACIZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bevacizumab BEVACIZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bevacizumab BEVACIZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bevacizumab BEVACIZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bevacizumab BEVACIZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bortezomib Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Bortezomib BORTEZOMIB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Cetuximab CETUXIMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Cetuximab CETUXIMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Cetuximab CETUXIMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Cetuximab CETUXIMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Cetuximab CETUXIMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Crisantaspase CRISANTASPASE Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Dacarbazine and Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Dacarbazine and temozolomide TEMOZOLOMIDE Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Dacarbazine and temozolomide TEMOZOLOMIDE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Dacarbazine and temozolomide- >DACARBAZINE Dacarbazine Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Hydroxycarbamide Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Hydroxycarbamide- >HYDROXYCARBAMIDE Hydroxycarbamide Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Ipilimumab IPILIMUMAB NICE-approved

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Pentostatin Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Platinum compounds Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Platinum compounds Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Platinum compounds Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Platinum compounds OXALIPLATIN Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Platinum compounds- >CARBOPLATIN Carboplatin Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Platinum compounds- >CISPLATIN Cisplatin Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Procarbazine Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Procarbazine->PROCARBAZINE Procarbazine Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors VEMURAFENIB NICE-approved

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors AXITINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors CRIZOTINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors DASATINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors DASATINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors ERLOTINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors ERLOTINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors ERLOTINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors EVEROLIMUS Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors EVEROLIMUS Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors GEFITINIB Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors IMATINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors IMATINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors IMATINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors IMATINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors IMATINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors IMATINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors NILOTINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors NILOTINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors PAZOPANIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors SORAFENIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors SORAFENIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors SUNITINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors SUNITINIB Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Protein kinase inhibitors SUNITINIB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Taxanes Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Taxanes DOCETAXEL Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Taxanes Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Taxanes PACLITAXEL Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Taxanes PACLITAXEL Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Taxanes->PACLITAXEL Paclitaxel Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Topoisomerase I inhibitors HYDROCHLORIDE Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Topoisomerase I inhibitors Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Topoisomerase I inhibitors TOPOTECAN Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Topoisomerase I inhibitors TOPOTECAN Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Trabectedin NICE-approved 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Trabectedin TRABECTEDIN NICE-approved 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Trastuzumab TRASTUZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Trastuzumab TRASTUZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Trastuzumab TRASTUZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Trastuzumab TRASTUZUMAB Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >8.1.5 Other antineoplastic drugs->Tretinoin Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >Treatment for cytotoxic-induced side-effects->Anthracycline side- effects DEXRAZOXANE Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >Treatment for cytotoxic-induced side-effects->Chemotherapy- induced mucositis and myelosuppression FOLINIC ACID Restricted 8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >Treatment for cytotoxic-induced side-effects->Chemotherapy- induced mucositis and myelosuppression->FOLINIC ACID->Calcium folinate Calcium Folinate Restricted

8 Malignant disease and immunosuppression->8.1 Cytotoxic drugs- >Treatment for cytotoxic-induced side-effects->Urothelial MESNA Restricted

8 Malignant disease and immunosuppression->8.2 Drugs affecting Anti-lymphocyte monoclonal the immune response antibodies Restricted

8 Malignant disease and immunosuppression->8.2 Drugs affecting Antiproliferative the immune response immunosuppressants Restricted

8 Malignant disease and immunosuppression->8.2 Drugs affecting Corticosteroids and other the immune response immunosuppressants Restricted

8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response Other immunomodulating drugs Restricted

8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.1 Antiproliferative immunosuppressants AZATHIOPRINE Restricted

8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.1 Antiproliferative immunosuppressants MYCOPHENOLATE MOFETIL Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.1 Antiproliferative immunosuppressants- >AZATHIOPRINE Azathioprine Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.2 Corticosteroids and other immunosuppressants CICLOSPORIN Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.2 Corticosteroids and other immunosuppressants TACROLIMUS Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.2 Corticosteroids and other immunosuppressants->CICLOSPORIN Capimune® Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.2 Corticosteroids and other immunosuppressants->CICLOSPORIN Neoral® Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.3 Anti-lymphocyte monoclonal antibodies RITUXIMAB Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.3 Anti-lymphocyte monoclonal antibodies RITUXIMAB Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.3 Anti-lymphocyte monoclonal antibodies RITUXIMAB Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.3 Anti-lymphocyte monoclonal antibodies RITUXIMAB Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.3 Anti-lymphocyte monoclonal antibodies RITUXIMAB Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.3 Anti-lymphocyte monoclonal antibodies RITUXIMAB Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs->BCG bladder instillation BACILLUS CALMETTE-GUÉRIN Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs- >Fingolimod FINGOLIMOD NICE-approved 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs- >Interferon alfa INTERFERON ALFA Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs- >Interferon alfa PEGINTERFERON ALFA Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs- >Interferon alfa PEGINTERFERON ALFA Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs- >Interferon alfa->INTERFERON ALFA Roferon-A® Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs- >Lenalidomide, pomalidomide, and LENALIDOMIDE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs- >Lenalidomide, pomalidomide, and thalidomide THALIDOMIDE Restricted 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs- >Mifamurtide MIFAMURTIDE NICE-approved 8 Malignant disease and immunosuppression->8.2 Drugs affecting the immune response->8.2.4 Other immunomodulating drugs- >Natalizumab NATALIZUMAB NICE-approved 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease Androgens Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease Oestrogens Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease Progestogens Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.1 Oestrogens Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.1 Oestrogens ETHINYLESTRADIOL Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.1 Oestrogens- >DIETHYLSTILBESTROL Diethylstilbestrol Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.2 Progestogens NORETHISTERONE On Formulary

8 Malignant disease and immunosuppression->8.3 Sex hormones MEDROXYPROGESTERONE and hormone antagonists in malignant disease->8.3.2 Progestogens ACETATE Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.2 Progestogens Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists Restricted Gonadorelin analogues and 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone gonadotrophin-releasing antagonists hormone antagonists Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists Somatostatin analogues Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.1 Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.1 Breast cancer Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.1 Breast cancer Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.1 Breast cancer Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.1 Breast cancer->TAMOXIFEN Tamoxifen Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Anti-androgens CYPROTERONE ACETATE On Formulary

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Anti-androgens Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Anti-androgens Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Anti-androgens Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Anti-androgens->CYPROTERONE ACETATE Cyproterone Acetate On Formulary

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Anti-androgens->FLUTAMIDE Flutamide Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Gonadorelin analogues GOSERELIN Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Gonadorelin analogues LEUPRORELIN ACETATE Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Gonadorelin analogues TRIPTORELIN Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Gonadorelin analogues- >GOSERELIN Zoladex® Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.2 Gonadorelin analogues and gonadotrophin- releasing hormone antagonists->Gonadorelin analogues- >GOSERELIN Zoladex® LA Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.3 Somatostatin analogues LANREOTIDE Restricted 8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.3 Somatostatin analogues OCTREOTIDE Restricted

8 Malignant disease and immunosuppression->8.3 Sex hormones and hormone antagonists in malignant disease->8.3.4 Hormone antagonists->8.3.4.3 Somatostatin analogues->OCTREOTIDE Depot preparation Restricted 9 Nutrition and ->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias Parenteral iron On Formulary 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.1 Oral iron FERROUS FUMARATE On Formulary 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.1 Oral iron FERROUS SULFATE On Formulary 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.1 Oral iron SODIUM FEREDETATE On Formulary 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.1 Oral iron- >FERROUS SULFATE Ferrous Sulfate On Formulary 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.1 Oral iron- >FERROUS SULFATE->With folic acid Ferrograd Folic® On Formulary 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.1 Oral iron- >SODIUM FEREDETATE Sytron® On Formulary

9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.2 Parenteral iron IRON DEXTRAN On Formulary

9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.2 Parenteral iron IRON SUCROSE On Formulary

9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.2 Parenteral iron FERRIC CARBOXYMALTOSE Restricted 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.1 Iron-deficiency anaemias->9.1.1.2 Parenteral iron- >IRON DEXTRAN CosmoFer® On Formulary 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.2 Drugs used in megaloblastic anaemias FOLIC ACID On Formulary 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.2 Drugs used in megaloblastic anaemias HYDROXOCOBALAMIN On Formulary

9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.2 Drugs used in megaloblastic anaemias->FOLIC ACID Folic Acid On Formulary 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.2 Drugs used in megaloblastic anaemias- >HYDROXOCOBALAMIN Hydroxocobalamin On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias->Erythropoietins DARBEPOETIN ALFA Restricted 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in hypoplastic, haemolytic, and renal EPOETIN ALFA, BETA, THETA, and anaemias->Erythropoietins ZETA Restricted 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias->Iron overload DEFERIPRONE Restricted 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias->Iron overload DESFERRIOXAMINE MESILATE Restricted 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.3 Drugs used in hypoplastic, haemolytic, and renal anaemias->Iron overload->DESFERRIOXAMINE MESILATE Desferrioxamine mesilate Restricted 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.4 Drugs used in disorders->Idiopathic thrombocytopenic purpura NICE-approved 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.4 Drugs used in platelet disorders->Idiopathic thrombocytopenic purpura ROMIPLOSTIM NICE-approved 9 Nutrition and blood->9.1 Anaemias and some other blood disorders->9.1.6 Drugs used in LENOGRASTIM Restricted 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.1 Oral preparations for fluid and electrolyte imbalance->9.2.1.1 Oral potassium POTASSIUM CHLORIDE On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.1 Oral preparations for fluid and electrolyte imbalance->9.2.1.1 Oral potassium->Management of hyperkalaemia POLYSTYRENE SULFONATE RESINS On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.1 Oral preparations for fluid and electrolyte imbalance->9.2.1.1 Oral potassium->Management of hyperkalaemia->POLYSTYRENE SULFONATE RESINS Calcium Resonium® On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.1 Oral preparations for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and SODIUM CHLORIDE On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.1 Oral preparations for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and water->Oral rehydration therapy (ORT) ORAL REHYDRATION SALTS (ORS) On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.1 Oral preparations for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and water->Oral rehydration therapy (ORT)->ORAL REHYDRATION SALTS (ORS)->UK formulations Dioralyte® On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.1 Oral preparations for fluid and electrolyte imbalance->9.2.1.2 Oral sodium and water->SODIUM CHLORIDE Slow Sodium® On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.1 Oral preparations for fluid and electrolyte imbalance->9.2.1.3 Oral bicarbonate SODIUM BICARBONATE On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.1 Oral preparations for fluid and electrolyte imbalance->9.2.1.3 Oral bicarbonate->SODIUM BICARBONATE Sodium Bicarbonate On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Bicarbonate and lactate SODIUM BICARBONATE On Formulary This formulary was published on 8th January 2014

Formulary Sec tion Title Status 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Bicarbonate and lactate->SODIUM Sodium Bicarbonate Intravenous BICARBONATE Infusion On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous glucose GLUCOSE On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous glucose->GLUCOSE Glucose Intravenous Infusion On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous potassium POTASSIUM CHLORIDE On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous potassium->POTASSIUM Potassium Chloride and Glucose CHLORIDE Intravenous Infusion On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous potassium->POTASSIUM Potassium Chloride and Sodium CHLORIDE Chloride Intravenous Infusion On Formulary

9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral Potassium Chloride, Sodium preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous potassium->POTASSIUM Chloride, and Glucose CHLORIDE Intravenous Infusion On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous potassium->POTASSIUM Potassium Chloride Concentrate, CHLORIDE Sterile Restricted 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous sodium SODIUM CHLORIDE On Formulary

9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Sodium Chloride Intravenous Electrolytes and water->Intravenous sodium->SODIUM CHLORIDE Infusion On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous sodium->SODIUM CHLORIDE- >With other ingredients Ringer's Solution for Injection On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous sodium->SODIUM CHLORIDE- Sodium Chloride and Glucose >With other ingredients Intravenous Infusion On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Intravenous sodium->SODIUM CHLORIDE- Sodium Lactate Intravenous >With other ingredients Infusion, Compound On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.1 Electrolytes and water->Water Water for Injections On Formulary 9 Nutrition and blood->9.2 Fluids and electrolytes->9.2.2 Parenteral preparations for fluid and electrolyte imbalance->9.2.2.2 Plasma and plasma substitutes ALBUMIN SOLUTION On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 9 Nutrition and blood->9.3 Intravenous nutrition->Supplementary preparations Addiphos® Restricted 9 Nutrition and blood->9.3 Intravenous nutrition->Supplementary preparations Additrace® Restricted 9 Nutrition and blood->9.3 Intravenous nutrition->Supplementary preparations Peditrace® Restricted 9 Nutrition and blood->9.3 Intravenous nutrition->Supplementary preparations Solivito N® Restricted 9 Nutrition and blood->9.3 Intravenous nutrition->Supplementary preparations Vitlipid N® Restricted

9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium Magnesium On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.1 Calcium supplements CALCIUM SALTS On Formulary

9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.1 Calcium supplements->CALCIUM SALTS->Oral preparations Adcal® On Formulary

9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.1 Calcium supplements->CALCIUM SALTS->Oral preparations Calcichew® On Formulary

9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.1 Calcium supplements->CALCIUM SALTS->Oral preparations Calcium-Sandoz® On Formulary

9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.1 Calcium supplements->CALCIUM SALTS->Oral preparations Sandocal® On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.1 Calcium supplements->CALCIUM SALTS->Parenteral preparations Calcium Chloride On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.1 Calcium supplements->CALCIUM SALTS->Parenteral preparations Calcium Gluconate On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.2 and hypercalciuria CINACALCET Restricted 9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.3 Magnesium On Formulary

9 Nutrition and blood->9.5 Minerals->9.5.1 Calcium and magnesium- >9.5.1.3 Magnesium->MAGNESIUM SULFATE Magnesium Sulfate Injection, BP On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.2 Phosphorus Phosphate supplements On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.2 Phosphorus->9.5.2.1 Phosphate supplements Phosphate-Sandoz® On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents CALCIUM SALTS On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents SEVELAMER CARBONATE Restricted 9 Nutrition and blood->9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents->CALCIUM SALTS Adcal® On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents->CALCIUM SALTS Calcium-500 On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.2 Phosphorus->9.5.2.2 Phosphate-binding agents->CALCIUM SALTS Phosex® On Formulary 9 Nutrition and blood->9.5 Minerals->9.5.4 ZINC SULFATE Restricted 9 Nutrition and blood->9.5 Minerals->9.5.4 Zinc->ZINC SULFATE Zinc Sulfate On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 9 Nutrition and blood->9.6 Vitamins Multivitamin preparations On Formulary 9 Nutrition and blood->9.6 Vitamins Restricted 9 Nutrition and blood->9.6 Vitamins->9.6.1 Vitamin A->VITAMIN A Vitamins A and D Restricted 9 Nutrition and blood->9.6 Vitamins->9.6.2 Vitamin B group PYRIDOXINE HYDROCHLORIDE On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.2 Vitamin B group RIBOFLAVIN On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.2 Vitamin B group THIAMINE On Formulary

9 Nutrition and blood->9.6 Vitamins->9.6.2 Vitamin B group->Oral Vitamin B Tablets, Compound, vitamin B complex preparations Strong On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.2 Vitamin B group- >PYRIDOXINE HYDROCHLORIDE Pyridoxine On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.2 Vitamin B group- >THIAMINE Pabrinex® On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.2 Vitamin B group- >THIAMINE Thiamine On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.3 Vitamin C ASCORBIC ACID On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.3 Vitamin C->ASCORBIC ACID Ascorbic Acid On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.4 Vitamin D ALFACALCIDOL On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.4 Vitamin D ERGOCALCIFEROL On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.4 Vitamin D COLECALCIFEROL Restricted 9 Nutrition and blood->9.6 Vitamins->9.6.4 Vitamin D- >ALFACALCIDOL Alfacalcidol On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.4 Vitamin D- >COLECALCIFEROL->With calcium Adcal-D3® Restricted 9 Nutrition and blood->9.6 Vitamins->9.6.4 Vitamin D- >ERGOCALCIFEROL->Daily supplements Calcium and Ergocalciferol On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.4 Vitamin D- >ERGOCALCIFEROL->Pharmacological strengths Ergocalciferol On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.5 Vitamin E ALPHA TOCOPHERYL ACETATE Restricted 9 Nutrition and blood->9.6 Vitamins->9.6.5 Vitamin E->ALPHA TOCOPHERYL ACETATE Vitamin E Suspension Restricted 9 Nutrition and blood->9.6 Vitamins->9.6.6 Vitamin K MENADIOL SODIUM PHOSPHATE On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.6 Vitamin K PHYTOMENADIONE On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.6 Vitamin K->MENADIOL SODIUM PHOSPHATE Menadiol Phosphate On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.6 Vitamin K- >PHYTOMENADIONE->Colloidal formulation Konakion® MM On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.6 Vitamin K- >PHYTOMENADIONE->Colloidal formulation Konakion® MM Paediatric On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.7 Multivitamin preparations Abidec® On Formulary 9 Nutrition and blood->9.6 Vitamins->9.6.7 Multivitamin preparations Dalivit® Restricted 9 Nutrition and blood->9.8 Metabolic disorders->9.8.1 Drugs used in metabolic disorders Carnitine deficiency Restricted 9 Nutrition and blood->9.8 Metabolic disorders->9.8.1 Drugs used in metabolic disorders->Carnitine deficiency CARNITINE Restricted 9 Nutrition and blood->9.8 Metabolic disorders->9.8.1 Drugs used in metabolic disorders->Urea cycle disorders SODIUM PHENYLBUTYRATE Restricted 9 Nutrition and blood->9.8 Metabolic disorders->9.8.1 Drugs used in metabolic disorders->Wilson's disease PENICILLAMINE Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status 9 Nutrition and blood->9.8 Metabolic disorders->9.8.1 Drugs used in metabolic disorders->Wilson's disease TRIENTINE DIHYDROCHLORIDE Restricted 9 Nutrition and blood->9.8 Metabolic disorders->9.8.1 Drugs used in metabolic disorders->Wilson's disease->TRIENTINE DIHYDROCHLORIDE Trientine Dihydrochloride Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs SODIUM Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->DICLOFENAC SODIUM Diclofenac Sodium Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->DICLOFENAC SODIUM->With misoprostol Arthrotec® Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->ETODOLAC->Modified release Lodine SR® On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->FLURBIPROFEN Flurbiprofen Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->IBUPROFEN Ibuprofen On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->INDOMETACIN Indometacin On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->MEFENAMIC ACID Mefenamic Acid Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->NABUMETONE Nabumetone On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->NAPROXEN Naproxen On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.1 Non-steroidal anti- inflammatory drugs->PIROXICAM Feldene® Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.2 Corticosteroids->10.1.2.2 Local LOCAL corticosteroid injections INJECTIONS On Formulary

10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.2 Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS On Formulary

10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.2 Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS Methylprednisolone acetate On Formulary

10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.2 Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.2 Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS- >Hydrocortisone acetate Hydrocortistab® On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.2 Corticosteroids->10.1.2.2 Local corticosteroid injections->LOCAL CORTICOSTEROID INJECTIONS- >Methylprednisolone acetate Depo-Medrone® On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Antimalarials HYDROXYCHLOROQUINE SULFATE On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ABATACEPT NICE-approved 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ABATACEPT NICE-approved 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators TOCILIZUMAB NICE-approved 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ADALIMUMAB Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ADALIMUMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ADALIMUMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ADALIMUMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators CERTOLIZUMAB PEGOL Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ETANERCEPT Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ETANERCEPT Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ETANERCEPT Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators ETANERCEPT Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators GOLIMUMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators GOLIMUMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators GOLIMUMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators INFLIXIMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators INFLIXIMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators INFLIXIMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators INFLIXIMAB Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Cytokine modulators RITUXIMAB Restricted

10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Drugs affecting the immune response AZATHIOPRINE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Drugs affecting the immune response CICLOSPORIN Restricted

10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Drugs affecting the immune response LEFLUNOMIDE Restricted

10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Drugs affecting the immune response METHOTREXATE Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Drugs affecting the immune response- >METHOTREXATE Methotrexate Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Gold SODIUM AUROTHIOMALATE Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Gold->SODIUM AUROTHIOMALATE Myocrisin® Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Penicillamine PENICILLAMINE Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Penicillamine->PENICILLAMINE Penicillamine Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Sulfasalazine SULFASALAZINE On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.3 Drugs that suppress the rheumatic disease process->Sulfasalazine->SULFASALAZINE Sulfasalazine On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and cytotoxic-induced hyperuricaemia->Acute attacks of gout COLCHICINE On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and cytotoxic-induced hyperuricaemia->Acute attacks of gout->COLCHICINE Colchicine On Formulary

10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and cytotoxic-induced hyperuricaemia->Hyperuricaemia associated with cytotoxic drugs RASBURICASE Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and cytotoxic-induced hyperuricaemia->Long-term control of gout ALLOPURINOL On Formulary 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and cytotoxic-induced hyperuricaemia->Long-term control of gout FEBUXOSTAT Restricted 10 Musculoskeletal and joint diseases->10.1 Drugs used in rheumatic diseases and gout->10.1.4 Gout and cytotoxic-induced hyperuricaemia->Long-term control of gout->ALLOPURINOL Allopurinol On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.1 Drugs that enhance neuromuscular transmission->Anticholinesterases NEOSTIGMINE Restricted 10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.1 Drugs that enhance neuromuscular transmission->Anticholinesterases PYRIDOSTIGMINE BROMIDE Restricted

10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.1 Drugs that enhance neuromuscular transmission->Anticholinesterases->NEOSTIGMINE Neostigmine Restricted 10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.2 relaxants BACLOFEN On Formulary 10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle relaxants DANTROLENE SODIUM On Formulary 10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle relaxants DIAZEPAM On Formulary 10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle relaxants Restricted 10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle relaxants- >BACLOFEN Baclofen On Formulary 10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle relaxants- >Nocturnal leg QUININE On Formulary 10 Musculoskeletal and joint diseases->10.2 Drugs used in neuromuscular disorders->10.2.2 Skeletal muscle relaxants- >TIZANIDINE Tizanidine Restricted 10 Musculoskeletal and joint diseases->10.3 Drugs for the treatment of soft- disorders and topical pain relief->10.3.1 - >Hyaluronidase HYALURONIDASE On Formulary 10 Musculoskeletal and joint diseases->10.3 Drugs for the treatment of soft-tissue disorders and topical pain relief->10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices Capsaicin Restricted

10 Musculoskeletal and joint diseases->10.3 Drugs for the treatment of soft-tissue disorders and topical pain relief->10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices->Capsaicin Axsain® Restricted

10 Musculoskeletal and joint diseases->10.3 Drugs for the treatment of soft-tissue disorders and topical pain relief->10.3.2 Rubefacients, topical NSAIDs, capsaicin, and poultices->Capsaicin Zacin® Restricted

11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials CHLORAMPHENICOL On Formulary

11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials GENTAMICIN On Formulary

11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials AZITHROMYCIN DIHYDRATE Restricted

11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials CIPROFLOXACIN Restricted

11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials FUSIDIC ACID Restricted

11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials LEVOFLOXACIN Restricted

11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials OFLOXACIN Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status

11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials PROPAMIDINE ISETIONATE Restricted 11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials- >CHLORAMPHENICOL Chloramphenicol On Formulary 11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials- >CHLORAMPHENICOL Single use On Formulary 11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials- >CHLORAMPHENICOL->Single use Minims® Chloramphenicol On Formulary 11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials- >CIPROFLOXACIN Ciloxan® Restricted 11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials- >FUSIDIC ACID Fucithalmic® Restricted 11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials- >GENTAMICIN Genticin® On Formulary 11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials- >LEVOFLOXACIN Oftaquix® Restricted 11 Eye->11.3 Anti-infective eye preparations->11.3.1 Antibacterials- >OFLOXACIN Exocin® Restricted 11 Eye->11.3 Anti-infective eye preparations->11.3.3 Antivirals ACICLOVIR On Formulary 11 Eye->11.3 Anti-infective eye preparations->11.3.3 Antivirals GANCICLOVIR Restricted 11 Eye->11.3 Anti-infective eye preparations->11.3.3 Antivirals- >ACICLOVIR Zovirax® On Formulary 11 Eye->11.3 Anti-infective eye preparations->11.3.3 Antivirals- >GANCICLOVIR Virgan® Restricted 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids BETAMETHASONE On Formulary 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids DEXAMETHASONE On Formulary 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids PREDNISOLONE On Formulary 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids Restricted 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids ETABONATE Restricted 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids->DEXAMETHASONE->Single use Minims® Dexamethasone On Formulary 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids->DEXAMETHASONE->With antibacterials Maxitrol® On Formulary

11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids->Intravitreal corticosteroids DEXAMETHASONE Restricted 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids->Intravitreal corticosteroids- >DEXAMETHASONE Ozurdex® Restricted 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids->PREDNISOLONE Pred Forte® On Formulary 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.1 Corticosteroids->PREDNISOLONE Predsol® On Formulary

11 Eye->11.4 Corticosteroids and other anti-inflammatory Minims® Prednisolone Sodium preparations->11.4.1 Corticosteroids->PREDNISOLONE->Single use Phosphate On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.2 Other anti-inflammatory preparations NEDOCROMIL SODIUM On Formulary 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.2 Other anti-inflammatory preparations OLOPATADINE On Formulary 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.2 Other anti-inflammatory preparations SODIUM CROMOGLICATE On Formulary 11 Eye->11.4 Corticosteroids and other anti-inflammatory preparations->11.4.2 Other anti-inflammatory preparations- >SODIUM CROMOGLICATE Sodium Cromoglicate On Formulary 11 Eye->11.5 Mydriatics and cycloplegics->Antimuscarinics ATROPINE SULFATE On Formulary CYCLOPENTOLATE 11 Eye->11.5 Mydriatics and cycloplegics->Antimuscarinics HYDROCHLORIDE On Formulary 11 Eye->11.5 Mydriatics and cycloplegics->Antimuscarinics TROPICAMIDE On Formulary 11 Eye->11.5 Mydriatics and cycloplegics->Antimuscarinics- >ATROPINE SULFATE Atropine On Formulary 11 Eye->11.5 Mydriatics and cycloplegics->Antimuscarinics- >ATROPINE SULFATE->Single use Minims® Atropine Sulphate On Formulary 11 Eye->11.5 Mydriatics and cycloplegics->Antimuscarinics- >CYCLOPENTOLATE HYDROCHLORIDE Mydrilate® On Formulary

11 Eye->11.5 Mydriatics and cycloplegics->Antimuscarinics- Minims® Cyclopentolate >CYCLOPENTOLATE HYDROCHLORIDE->Single use Hydrochloride On Formulary 11 Eye->11.5 Mydriatics and cycloplegics->Antimuscarinics- >TROPICAMIDE Mydriacyl® On Formulary 11 Eye->11.5 Mydriatics and cycloplegics->Antimuscarinics- >TROPICAMIDE->Single use Minims® Tropicamide On Formulary PHENYLEPHRINE 11 Eye->11.5 Mydriatics and cycloplegics->Sympathomimetics HYDROCHLORIDE On Formulary

11 Eye->11.5 Mydriatics and cycloplegics->Sympathomimetics- Minims® Phenylephrine >PHENYLEPHRINE HYDROCHLORIDE->Single use Hydrochloride On Formulary 11 Eye->11.6 Treatment of glaucoma->Beta-blockers On Formulary 11 Eye->11.6 Treatment of glaucoma->Beta-blockers On Formulary 11 Eye->11.6 Treatment of glaucoma->Beta-blockers HYDROCHLORIDE Restricted 11 Eye->11.6 Treatment of glaucoma->Beta-blockers->BETAXOLOL Betoptic® On Formulary 11 Eye->11.6 Treatment of glaucoma->Beta-blockers->CARTEOLOL HYDROCHLORIDE Teoptic® Restricted 11 Eye->11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL Timolol On Formulary 11 Eye->11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL Once-daily preparations Restricted 11 Eye->11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL With Restricted 11 Eye->11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL With dorzolamide Restricted 11 Eye->11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL With Restricted 11 Eye->11.6 Treatment of glaucoma->Beta-blockers->TIMOLOL- >Once-daily preparations Timoptol®-LA On Formulary 11 Eye->11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and systemic drugs ACETAZOLAMIDE On Formulary 11 Eye->11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and systemic drugs BRINZOLAMIDE On Formulary 11 Eye->11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and systemic drugs DORZOLAMIDE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

11 Eye->11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and systemic drugs->ACETAZOLAMIDE->Modified release Diamox® SR On Formulary 11 Eye->11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and systemic drugs->BRINZOLAMIDE Azopt® On Formulary 11 Eye->11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and systemic drugs->BRINZOLAMIDE->With timolol Azarga® Restricted 11 Eye->11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and systemic drugs->DORZOLAMIDE Dorzolamide Restricted 11 Eye->11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and systemic drugs->DORZOLAMIDE->With timolol Cosopt® Restricted 11 Eye->11.6 Treatment of glaucoma->Carbonic anhydrase inhibitors and systemic drugs->DORZOLAMIDE->With timolol Dorzolamide with Timolol Restricted 11 Eye->11.6 Treatment of glaucoma->Miotics PILOCARPINE On Formulary 11 Eye->11.6 Treatment of glaucoma->Miotics->PILOCARPINE Pilocarpine Hydrochloride On Formulary 11 Eye->11.6 Treatment of glaucoma->Miotics->PILOCARPINE- >Single use Minims® Pilocarpine Nitrate On Formulary 11 Eye->11.6 Treatment of glaucoma->Prostaglandin analogues and prostamides On Formulary 11 Eye->11.6 Treatment of glaucoma->Prostaglandin analogues and prostamides Restricted 11 Eye->11.6 Treatment of glaucoma->Prostaglandin analogues and prostamides LATANOPROST Restricted 11 Eye->11.6 Treatment of glaucoma->Prostaglandin analogues and prostamides Restricted 11 Eye->11.6 Treatment of glaucoma->Prostaglandin analogues and prostamides->BIMATOPROST Lumigan® Restricted 11 Eye->11.6 Treatment of glaucoma->Prostaglandin analogues and prostamides->BIMATOPROST->With timolol Ganfort® Restricted 11 Eye->11.6 Treatment of glaucoma->Prostaglandin analogues and prostamides->LATANOPROST Xalatan® Restricted 11 Eye->11.6 Treatment of glaucoma->Prostaglandin analogues and prostamides->TRAVOPROST Travatan® On Formulary 11 Eye->11.6 Treatment of glaucoma->Prostaglandin analogues and prostamides->TRAVOPROST->With timolol DuoTrav® Restricted 11 Eye->11.6 Treatment of glaucoma->Sympathomimetics BRIMONIDINE TARTRATE Restricted 11 Eye->11.6 Treatment of glaucoma->Sympathomimetics- >BRIMONIDINE TARTRATE Brimonidine Tartrate On Formulary 11 Eye->11.6 Treatment of glaucoma->Sympathomimetics- >BRIMONIDINE TARTRATE->With timolol Combigan® Restricted OXYBUPROCAINE 11 Eye->11.7 Local anaesthetics HYDROCHLORIDE On Formulary PROXYMETACAINE 11 Eye->11.7 Local anaesthetics HYDROCHLORIDE On Formulary 11 Eye->11.7 Local anaesthetics TETRACAINE HYDROCHLORIDE On Formulary

11 Eye->11.7 Local anaesthetics->OXYBUPROCAINE Minims® Oxybuprocaine HYDROCHLORIDE Hydrochloride On Formulary 11 Eye->11.7 Local anaesthetics->PROXYMETACAINE HYDROCHLORIDE Minims® Proxymetacaine On Formulary

11 Eye->11.7 Local anaesthetics->PROXYMETACAINE Minims® Proxymetacaine and HYDROCHLORIDE->With fluorescein Fluorescein On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status Minims® Tetracaine 11 Eye->11.7 Local anaesthetics->TETRACAINE HYDROCHLORIDE Hydrochloride On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents ACETYLCYSTEINE On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents CARBOMERS On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents CARMELLOSE SODIUM On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents HYPROMELLOSE On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents POLYVINYL ALCOHOL On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents SODIUM CHLORIDE On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents SODIUM HYALURONATE On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents MACROGOLS Restricted

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->ACETYLCYSTEINE Ilube® On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->CARBOMERS Liquivisc® On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->CARBOMERS GelTears® Restricted 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->CARBOMERS Viscotears® Restricted 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->CARMELLOSE SODIUM->Single use Celluvisc® On Formulary

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->HYPROMELLOSE Isopto Plain® On Formulary

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->LIQUID PARAFFIN Lacri-Lube® On Formulary

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->LIQUID PARAFFIN VitA-POS® On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->MACROGOLS->Single use Systane® Restricted

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->POLYVINYL ALCOHOL Liquifilm ® On Formulary

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->POLYVINYL ALCOHOL Sno Tears® On Formulary

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->SODIUM CHLORIDE Balanced Solution On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->SODIUM CHLORIDE Single use On Formulary

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->SODIUM CHLORIDE Sodium Chloride 0.9% Solutions On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->SODIUM HYALURONATE Hyabak® On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->SODIUM HYALURONATE Hylo-Forte® On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->SODIUM HYALURONATE Vismed® Multi On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->SODIUM HYALURONATE->Single use Clinitas® On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.1 Tear deficiency, ocular lubricants, and astringents->SODIUM HYALURONATE->Single use Vismed® On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular diagnostic preparations FLUORESCEIN SODIUM On Formulary

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular diagnostic preparations->FLUORESCEIN SODIUM Minims® Fluorescein Sodium On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs DICLOFENAC SODIUM On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs TROMETAMOL On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs ACETYLCHOLINE CHLORIDE Restricted 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs Restricted 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs CEFUROXIME Restricted

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs->APRACLONIDINE Iopidine® Restricted

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs->DICLOFENAC SODIUM Voltarol® Ophtha Multidose On Formulary 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs->DICLOFENAC SODIUM- >Single use Voltarol® Ophtha On Formulary This formulary was published on 8th January 2014

Formulary Sec tion Title Status 11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Ocular peri-operative drugs->KETOROLAC TROMETAMOL Acular® On Formulary

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Subfoveal choroidal neovascularisation AFLIBERCEPT NICE-approved

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Subfoveal choroidal neovascularisation RANIBIZUMAB Restricted

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Subfoveal choroidal neovascularisation RANIBIZUMAB Restricted

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Subfoveal choroidal neovascularisation RANIBIZUMAB Restricted

11 Eye->11.8 Miscellaneous ophthalmic preparations->11.8.2 Ocular diagnostic and peri-operative preparations and photodynamic treatment->Subfoveal choroidal neovascularisation Restricted 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective preparations CLOTRIMAZOLE On Formulary 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective preparations GENTAMICIN On Formulary 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective preparations NEOMYCIN SULFATE On Formulary 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective preparations CHLORAMPHENICOL Restricted

12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective preparations->CHLORAMPHENICOL Chloramphenicol Restricted 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective preparations->CLIOQUINOL->With corticosteroid Locorten-Vioform® Restricted 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-infective preparations->GENTAMICIN->With corticosteroid Gentisone® HC On Formulary

12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 BETAMETHASONE SODIUM Otitis externa->Anti-inflammatory preparations->Corticosteroids PHOSPHATE On Formulary

12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inflammatory preparations->Corticosteroids PIVALATE On Formulary

12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inflammatory preparations->Corticosteroids HYDROCORTISONE On Formulary

12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 PREDNISOLONE SODIUM Otitis externa->Anti-inflammatory preparations->Corticosteroids PHOSPHATE On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inflammatory preparations->Corticosteroids- >BETAMETHASONE SODIUM PHOSPHATE Vistamethasone® On Formulary 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inflammatory preparations->Corticosteroids- >FLUMETASONE PIVALATE With antibacterial Restricted 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inflammatory preparations->Corticosteroids- >FLUMETASONE PIVALATE->With antibacterial Locorten-Vioform® On Formulary 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inflammatory preparations->Corticosteroids- >HYDROCORTISONE->With antibacterial Gentisone® HC On Formulary 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.1 Otitis externa->Anti-inflammatory preparations->Corticosteroids- >PREDNISOLONE SODIUM PHOSPHATE Predsol® On Formulary 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.3 Removal of ear wax Olive Oil On Formulary 12 Ear, nose, and oropharynx->12.1 Drugs acting on the ear->12.1.3 Removal of ear wax Sodium Bicarbonate On Formulary 12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.1 Drugs used in nasal allergy->Antihistamines AZELASTINE HYDROCHLORIDE Restricted

12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.1 Drugs used in nasal allergy->Corticosteroids BECLOMETASONE DIPROPIONATE On Formulary

12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- BETAMETHASONE SODIUM >12.2.1 Drugs used in nasal allergy->Corticosteroids PHOSPHATE On Formulary 12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.1 Drugs used in nasal allergy->Corticosteroids FUROATE Restricted 12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.1 Drugs used in nasal allergy->Corticosteroids- >BECLOMETASONE DIPROPIONATE Beclometasone On Formulary 12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.1 Drugs used in nasal allergy->Corticosteroids- >BETAMETHASONE SODIUM PHOSPHATE Vistamethasone® On Formulary 12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.2 Topical nasal decongestants->Sympathomimetics EPHEDRINE HYDROCHLORIDE On Formulary

12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.2 Topical nasal decongestants->Sympathomimetics HYDROCHLORIDE On Formulary 12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.2 Topical nasal decongestants->Sympathomimetics- >EPHEDRINE HYDROCHLORIDE Ephedrine On Formulary 12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.2 Topical nasal decongestants->Sympathomimetics- >XYLOMETAZOLINE HYDROCHLORIDE Xylometazoline On Formulary 12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.3 Nasal preparations for infection->Nasal staphylococci Bactroban Nasal® On Formulary 12 Ear, nose, and oropharynx->12.2 Drugs acting on the nose- >12.2.3 Nasal preparations for infection->Nasal staphylococci Naseptin® On Formulary Drugs for oral ulceration and 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx inflammation On Formulary

12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx Lozenges and sprays On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.1 Drugs for oral ulceration and inflammation HYDROCHLORIDE On Formulary This formulary was published on 8th January 2014

Formulary Sec tion Title Status 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.1 Drugs for oral ulceration and inflammation CORTICOSTEROIDS On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.1 Drugs for oral ulceration and inflammation LOCAL ANAESTHETICS On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.1 Drugs for oral ulceration and inflammation SALICYLATES On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.1 Drugs for oral ulceration and inflammation->LOCAL ANAESTHETICS Lidocaine On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.1 Drugs for oral ulceration and inflammation->SALICYLATES- >Choline salicylate Choline Salicylate Dental Gel, BP On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.2 Oropharyngeal anti-infective drugs->Oropharyngeal fungal infections On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.2 Oropharyngeal anti-infective drugs->Oropharyngeal fungal infections NYSTATIN On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.4 Mouthwashes, gargles, and dentifrices CHLORHEXIDINE GLUCONATE On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.4 Mouthwashes, gargles, and dentifrices HYDROGEN PEROXIDE On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.4 Mouthwashes, gargles, and dentifrices SODIUM CHLORIDE On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.4 Mouthwashes, gargles, and dentifrices->CHLORHEXIDINE GLUCONATE Chlorhexidine On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.4 Mouthwashes, gargles, and dentifrices->HYDROGEN Hydrogen Peroxide Mouthwash, PEROXIDE BP On Formulary

12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- Sodium Chloride Mouthwash, >12.3.4 Mouthwashes, gargles, and dentifrices->SODIUM CHLORIDE Compound, BP On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.5 Treatment of dry mouth->Local treatment BioXtra® On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.5 Treatment of dry mouth->Local treatment Glandosane® On Formulary 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.5 Treatment of dry mouth->Local treatment Salivix® Restricted 12 Ear, nose, and oropharynx->12.3 Drugs acting on the oropharynx- >12.3.5 Treatment of dry mouth->Systemic treatment PILOCARPINE HYDROCHLORIDE On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.1 Antibacterial preparations->13.10.1.1 Antibacterial preparations only used topically MUPIROCIN On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.1 Antibacterial preparations->13.10.1.1 Antibacterial preparations only used topically NEOMYCIN SULFATE On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.1 Antibacterial preparations->13.10.1.1 Antibacterial preparations only used topically POLYMYXINS On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.1 Antibacterial preparations->13.10.1.1 Antibacterial preparations only used topically SILVER SULFADIAZINE Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 13 Skin->13.10 Anti-infective skin preparations->13.10.1 Antibacterial preparations->13.10.1.1 Antibacterial preparations only used topically->POLYMYXINS Polyfax® On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.1 Antibacterial preparations->13.10.1.2 Antibacterial preparations also used systemically FUSIDIC ACID Restricted 13 Skin->13.10 Anti-infective skin preparations->13.10.1 Antibacterial preparations->13.10.1.2 Antibacterial preparations also used systemically METRONIDAZOLE Restricted 13 Skin->13.10 Anti-infective skin preparations->13.10.1 Antibacterial preparations->13.10.1.2 Antibacterial preparations also used systemically->METRONIDAZOLE Acea® Restricted 13 Skin->13.10 Anti-infective skin preparations->13.10.1 Antibacterial preparations->13.10.1.2 Antibacterial preparations also used systemically->METRONIDAZOLE Anabact® Restricted 13 Skin->13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations CLOTRIMAZOLE On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations MICONAZOLE NITRATE On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations NYSTATIN On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations TERBINAFINE Restricted 13 Skin->13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations->CLOTRIMAZOLE Clotrimazole On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.2 Antifungal preparations->MICONAZOLE NITRATE Miconazole On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.3 Antiviral preparations ACICLOVIR On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.3 Antiviral preparations->ACICLOVIR Aciclovir On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.4 Parasiticidal preparations->Malathion MALATHION On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.4 Parasiticidal preparations->Permethrin PERMETHRIN On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.4 Parasiticidal preparations->Permethrin->PERMETHRIN Permethrin On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.5 Preparations for minor cuts and abrasions Cetrimide Cream, BP On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.5 Preparations for minor cuts and abrasions Proflavine Cream, BPC On Formulary 13 Skin->13.10 Anti-infective skin preparations->13.10.5 Preparations for minor cuts and abrasions->Collodion Collodion, Flexible, BP On Formulary

13 Skin->13.10 Anti-infective skin preparations->13.10.5 Preparations for minor cuts and abrasions->Preparations for boils Magnesium Sulfate Paste, BP On Formulary

13 Skin->13.10 Anti-infective skin preparations->13.10.5 Preparations for minor cuts and abrasions->Skin tissue adhesive Histoacryl® On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.1 and saline ALCOHOL On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.1 Alcohols and saline SODIUM CHLORIDE On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.1 Alcohols and saline->ALCOHOL Industrial Methylated Spirit, BP On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.1 Alcohols and saline->SODIUM CHLORIDE Normasol® On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.1 Alcohols and saline->SODIUM CHLORIDE Sodium Chloride On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.1 Alcohols and saline->SODIUM CHLORIDE Steripod® Sodium Chloride On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.2 Chlorhexidine salts CHLORHEXIDINE On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.2 Chlorhexidine salts->CHLORHEXIDINE Chlorhexidine 0.05% On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.2 Chlorhexidine salts->CHLORHEXIDINE Hibiscrub® On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.2 Chlorhexidine salts->CHLORHEXIDINE Hydrex® On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.2 Chlorhexidine salts->CHLORHEXIDINE Unisept® On Formulary

13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.2 Chlorhexidine salts->CHLORHEXIDINE->With cetrimide Tisept® On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.3 Cationic surfactants and soaps CETRIMIDE On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.4 Iodine POVIDONE?IODINE On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.6 Oxidisers and dyes HYDROGEN PEROXIDE On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.6 Oxidisers and dyes POTASSIUM PERMANGANATE On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.6 Oxidisers and dyes->HYDROGEN PEROXIDE Hydrogen Peroxide Solution, BP On Formulary 13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- >13.11.6 Oxidisers and dyes->POTASSIUM PERMANGANATE Permitabs® On Formulary

13 Skin->13.11 Skin cleansers, antiseptics, and desloughing agents- Potassium Permanganate >13.11.6 Oxidisers and dyes->POTASSIUM PERMANGANATE Solution On Formulary 13 Skin->13.13 Topical circulatory preparations Hirudoid® On Formulary

13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients With antimicrobials Restricted 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >13.2.1.1 Emollient bath and shower preparations Aqueous Cream, BP On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >13.2.1.1 Emollient bath and shower preparations Balneum® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >13.2.1.1 Emollient bath and shower preparations Dermalo® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >13.2.1.1 Emollient bath and shower preparations Doublebase® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >13.2.1.1 Emollient bath and shower preparations->With antimicrobials Dermol® Restricted 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >Non-proprietary emollient preparations Emulsifying Ointment, BP On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >Non-proprietary emollient preparations Hydrous Ointment, BP On Formulary

13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- Liquid and White Soft Paraffin >Non-proprietary emollient preparations Ointment, NPF On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >Non-proprietary emollient preparations Paraffin, White Soft, BP On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >Non-proprietary emollient preparations Paraffin, Yellow Soft, BP On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >Preparations containing Calmurid® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >Proprietary emollient preparations Cetraben® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >Proprietary emollient preparations Diprobase® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >Proprietary emollient preparations E45® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >Proprietary emollient preparations Unguentum M® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.1 Emollients- >With antimicrobials Dermol® Restricted

13 Skin->13.2 Emollient and barrier preparations->13.2.2 Barrier preparations->Non-proprietary barrier preparations Zinc and Ointment, BP On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.2 Barrier preparations->Proprietary barrier preparations Metanium® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.2 Barrier preparations->Proprietary barrier preparations Sprilon® On Formulary 13 Skin->13.2 Emollient and barrier preparations->13.2.2 Barrier preparations->Proprietary barrier preparations Sudocrem® On Formulary 13 Skin->13.3 Topical local anaesthetics and antipruritics CALAMINE On Formulary 13 Skin->13.3 Topical local anaesthetics and antipruritics CROTAMITON On Formulary 13 Skin->13.3 Topical local anaesthetics and antipruritics LEVOMENTHOL On Formulary 13 Skin->13.3 Topical local anaesthetics and antipruritics TOPICAL LOCAL ANAESTHETICS On Formulary 13 Skin->13.3 Topical local anaesthetics and antipruritics HYDROCHLORIDE Restricted 13 Skin->13.3 Topical local anaesthetics and antipruritics- >CALAMINE Calamine On Formulary 13 Skin->13.3 Topical local anaesthetics and antipruritics- >LEVOMENTHOL Levomenthol Cream, BP On Formulary 13 Skin->13.4 Topical corticosteroids BETAMETHASONE ESTERS On Formulary 13 Skin->13.4 Topical corticosteroids On Formulary 13 Skin->13.4 Topical corticosteroids HYDROCORTISONE On Formulary 13 Skin->13.4 Topical corticosteroids On Formulary 13 Skin->13.4 Topical corticosteroids MOMETASONE FUROATE On Formulary 13 Skin->13.4 Topical corticosteroids TRIAMCINOLONE ACETONIDE On Formulary 13 Skin->13.4 Topical corticosteroids PROPIONATE Restricted 13 Skin->13.4 Topical corticosteroids BUTYRATE Restricted 13 Skin->13.4 Topical corticosteroids ACETONIDE Restricted 13 Skin->13.4 Topical corticosteroids->BETAMETHASONE ESTERS On Formulary 13 Skin->13.4 Topical corticosteroids->BETAMETHASONE ESTERS Betnovate-RD® On Formulary 13 Skin->13.4 Topical corticosteroids->BETAMETHASONE ESTERS Betnovate® On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 13 Skin->13.4 Topical corticosteroids->BETAMETHASONE ESTERS With antimicrobials Restricted 13 Skin->13.4 Topical corticosteroids->BETAMETHASONE ESTERS With Restricted 13 Skin->13.4 Topical corticosteroids->BETAMETHASONE ESTERS- >With antimicrobials Betamethasone and clioquinol Restricted 13 Skin->13.4 Topical corticosteroids->BETAMETHASONE ESTERS- >With antimicrobials Betamethasone and neomycin Restricted 13 Skin->13.4 Topical corticosteroids->BETAMETHASONE ESTERS- >With antimicrobials Lotriderm® Restricted 13 Skin->13.4 Topical corticosteroids->BETAMETHASONE ESTERS- >With salicylic acid Diprosalic® Restricted 13 Skin->13.4 Topical corticosteroids->CLOBETASOL PROPIONATE Dermovate® Restricted

13 Skin->13.4 Topical corticosteroids->CLOBETASOL PROPIONATE- Clobetasol with neomycin and >With antimicrobials nystatin Restricted 13 Skin->13.4 Topical corticosteroids->CLOBETASONE BUTYRATE Eumovate® Restricted 13 Skin->13.4 Topical corticosteroids->CLOBETASONE BUTYRATE- >With antimicrobials Trimovate® Restricted 13 Skin->13.4 Topical corticosteroids->FLUDROXYCORTIDE Haelan® On Formulary 13 Skin->13.4 Topical corticosteroids->HYDROCORTISONE Hydrocortisone On Formulary

13 Skin->13.4 Topical corticosteroids->HYDROCORTISONE BUTYRATE Locoid® On Formulary 13 Skin->13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials Canesten HC® On Formulary 13 Skin->13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials Daktacort® On Formulary 13 Skin->13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials Timodine® On Formulary 13 Skin->13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials Fucidin H® Restricted 13 Skin->13.4 Topical corticosteroids->HYDROCORTISONE->With antimicrobials Nystaform-HC® Restricted 13 Skin->13.4 Topical corticosteroids->MOMETASONE FUROATE Elocon® On Formulary 13 Skin->13.4 Topical corticosteroids->TRIAMCINOLONE ACETONIDE->With antimicrobials Aureocort® On Formulary Drugs affecting the immune 13 Skin->13.5 Preparations for eczema and psoriasis response Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.1 Preparations for eczema->Oral for eczema Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.1 Preparations for eczema->Topical preparations for eczema ICHTHAMMOL On Formulary 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Oral for psoriasis ACITRETIN Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis- >Dithranol DITHRANOL On Formulary 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis- >Dithranol->DITHRANOL->Non-proprietary preparations Dithranol Ointment, BP On Formulary 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis- >Dithranol->DITHRANOL->Proprietary preparations Dithrocream® On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis- >Salicylic acid SALICYLIC ACID On Formulary

13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis->Tars TARS On Formulary 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis->Tars- >TARS Non-proprietary preparations On Formulary 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis->Tars- >TARS->Proprietary preparations Sebco® On Formulary 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis- >Vitamin D and analogues CALCIPOTRIOL Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis- >Vitamin D and analogues TACALCITOL Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis- >Vitamin D and analogues->CALCIPOTRIOL Calcipotriol Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.2 Preparations for psoriasis->Topical preparations for psoriasis- >Vitamin D and analogues->TACALCITOL Curatoderm® Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.3 Drugs affecting the immune response PIMECROLIMUS NICE-approved 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.3 Drugs affecting the immune response CICLOSPORIN Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.3 Drugs affecting the immune response METHOTREXATE Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.3 Drugs affecting the immune response TACROLIMUS Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.3 Drugs affecting the immune response->Cytokine modulators ADALIMUMAB Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.3 Drugs affecting the immune response->Cytokine modulators ETANERCEPT Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.3 Drugs affecting the immune response->Cytokine modulators INFLIXIMAB Restricted 13 Skin->13.5 Preparations for eczema and psoriasis->13.5.3 Drugs affecting the immune response->Cytokine modulators USTEKINUMAB Restricted 13 Skin->13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Benzoyl peroxide and azelaic acid BENZOYL PEROXIDE On Formulary 13 Skin->13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Benzoyl peroxide and azelaic acid->BENZOYL PEROXIDE With antimicrobials Restricted 13 Skin->13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical antibacterials for acne ANTIBACTERIALS Restricted 13 Skin->13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical antibacterials for acne->ANTIBACTERIALS Dalacin T® On Formulary 13 Skin->13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical retinoids and related preparations for acne ADAPALENE Restricted 13 Skin->13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical retinoids and related preparations for acne ISOTRETINOIN Restricted 13 Skin->13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical retinoids and related preparations for acne TRETINOIN Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 13 Skin->13.6 Acne and rosacea->13.6.1 Topical preparations for acne->Topical retinoids and related preparations for acne- >ADAPALENE Differin® Restricted 13 Skin->13.6 Acne and rosacea->13.6.2 Oral preparations for acne- >Hormone treatment for acne CO-CYPRINDIOL Restricted 13 Skin->13.6 Acne and rosacea->13.6.2 Oral preparations for acne- >Hormone treatment for acne->CO-CYPRINDIOL Co-cyprindiol Restricted 13 Skin->13.6 Acne and rosacea->13.6.2 Oral preparations for acne- >Oral retinoid for acne ISOTRETINOIN Restricted 13 Skin->13.6 Acne and rosacea->13.6.2 Oral preparations for acne- >Oral retinoid for acne->ISOTRETINOIN Isotretinoin Restricted 13 Skin->13.7 Preparations for warts and calluses SILVER NITRATE On Formulary 13 Skin->13.7 Preparations for warts and calluses SALICYLIC ACID Restricted

13 Skin->13.7 Preparations for warts and calluses->Anogenital warts PODOPHYLLOTOXIN On Formulary

13 Skin->13.7 Preparations for warts and calluses->Anogenital warts IMIQUIMOD Restricted

13 Skin->13.7 Preparations for warts and calluses->SALICYLIC ACID Salactol® On Formulary

13 Skin->13.7 Preparations for warts and calluses->SALICYLIC ACID Occlusal® Restricted

13 Skin->13.7 Preparations for warts and calluses->SALICYLIC ACID Salatac® Restricted 13 Skin->13.8 Sunscreens and camouflagers Camouflagers Restricted 13 Skin->13.8 Sunscreens and camouflagers->13.8.1 Sunscreen preparations Sunsense® Ultra Restricted 13 Skin->13.8 Sunscreens and camouflagers->13.8.1 Sunscreen preparations->Photodamage DICLOFENAC SODIUM Restricted 13 Skin->13.8 Sunscreens and camouflagers->13.8.1 Sunscreen preparations->Photodamage FLUOROURACIL Restricted 13 Skin->13.9 Shampoos and other preparations for scalp and hair conditions->Androgenetic alopecia FINASTERIDE Restricted 13 Skin->13.9 Shampoos and other preparations for scalp and hair conditions->Androgenetic alopecia MINOXIDIL Restricted 13 Skin->13.9 Shampoos and other preparations for scalp and hair conditions->Other scalp preparations Polytar Plus® On Formulary 13 Skin->13.9 Shampoos and other preparations for scalp and hair conditions->Other scalp preparations Polytar® On Formulary 13 Skin->13.9 Shampoos and other preparations for scalp and hair conditions->Shampoos Capasal® On Formulary 13 Skin->13.9 Shampoos and other preparations for scalp and hair conditions->Shampoos Selsun® On Formulary 14 Immunological products and vaccines->14.4 Vaccines and antisera BCG vaccines On Formulary 14 Immunological products and vaccines->14.4 Vaccines and antisera Influenza vaccines On Formulary 14 Immunological products and vaccines->14.4 Vaccines and antisera Meningococcal vaccines On Formulary 14 Immunological products and vaccines->14.4 Vaccines and antisera Tetanus vaccines On Formulary 14 Immunological products and vaccines->14.4 Vaccines and antisera Typhoid vaccines On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 14 Immunological products and vaccines->14.4 Vaccines and antisera Diphtheria vaccines Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera Hepatitis A vaccine Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera Hepatitis B vaccine Restricted

14 Immunological products and vaccines->14.4 Vaccines and Measles, Mumps and Rubella antisera (MMR) vaccine Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera Pneumococcal vaccines Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera Rabies vaccine Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera Rotavirus vaccine Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera Varicella?zoster vaccines Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera->BCG vaccines->BACILLUS CALMETTE-GUÉRIN VACCINE- >Intradermal Bacillus Calmette-Guérin Vaccine On Formulary

14 Immunological products and vaccines->14.4 Vaccines and Tuberculin Purified Protein antisera->BCG vaccines->Diagnostic agents Derivative On Formulary Diphtheria-containing vaccines 14 Immunological products and vaccines->14.4 Vaccines and for children over 10 years and antisera->Diphtheria vaccines->DIPHTHERIA-CONTAINING VACCINES adults Restricted

14 Immunological products and vaccines->14.4 Vaccines and Diphtheria-containing vaccines antisera->Diphtheria vaccines->DIPHTHERIA-CONTAINING VACCINES for children under 10 years Restricted

14 Immunological products and vaccines->14.4 Vaccines and Adsorbed Diphtheria [low dose], antisera->Diphtheria vaccines->DIPHTHERIA-CONTAINING VACCINES->Diphtheria-containing vaccines for children over 10 Tetanus and Poliomyelitis years and adults (Inactivated) Vaccine Restricted

Adsorbed Diphtheria [low dose], 14 Immunological products and vaccines->14.4 Vaccines and Tetanus, Pertussis (Acellular, antisera->Diphtheria vaccines->DIPHTHERIA-CONTAINING VACCINES->Diphtheria-containing vaccines for children under 10 Component) and Poliomyelitis years (Inactivated) Vaccine Restricted Adsorbed Diphtheria, Tetanus, 14 Immunological products and vaccines->14.4 Vaccines and Pertussis (Acellular, Component) antisera->Diphtheria vaccines->DIPHTHERIA-CONTAINING VACCINES->Diphtheria-containing vaccines for children under 10 and Poliomyelitis (Inactivated) years Vaccine Restricted Diphtheria, Tetanus, Pertussis (Acellular, Component), 14 Immunological products and vaccines->14.4 Vaccines and Poliomyelitis (Inactivated) and antisera->Diphtheria vaccines->DIPHTHERIA-CONTAINING VACCINES->Diphtheria-containing vaccines for children under 10 Haemophilus Type b Conjugate years Vaccine (Adsorbed) Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera->Hepatitis A vaccine->HEPATITIS A VACCINE Single component Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera->Hepatitis A vaccine->HEPATITIS A VACCINE With typhoid vaccine Restricted This formulary was published on 8th January 2014

Formulary Sec tion Title Status 14 Immunological products and vaccines->14.4 Vaccines and antisera->Hepatitis B vaccine->HEPATITIS B VACCINE Single component Restricted

14 Immunological products and vaccines->14.4 Vaccines and MEASLES, MUMPS AND RUBELLA antisera->Measles, Mumps and Rubella (MMR) vaccine VACCINE, LIVE Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera->Pertussis vaccine Combined vaccines Restricted

14 Immunological products and vaccines->14.4 Vaccines and Pneumococcal polysaccharide antisera->Pneumococcal vaccines->PNEUMOCOCCAL VACCINE conjugate vaccine (adsorbed) Restricted

14 Immunological products and vaccines->14.4 Vaccines and Pneumococcal polysaccharide antisera->Pneumococcal vaccines->PNEUMOCOCCAL VACCINE vaccine Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera->Rotavirus vaccine ROTAVIRUS VACCINE Restricted

14 Immunological products and vaccines->14.4 Vaccines and Polysaccharide vaccine with antisera->Typhoid vaccines->TYPHOID VACCINE hepatitis A vaccine Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera->Typhoid vaccines->TYPHOID VACCINE->Typhoid vaccine, live (oral) Vivotif® Restricted 14 Immunological products and vaccines->14.4 Vaccines and antisera->Varicella?zoster vaccines->VARICELLA-ZOSTER VACCINE Varilrix® Restricted

14 Immunological products and vaccines->14.5 Immunoglobulins Disease-specific immunoglobulins Restricted

14 Immunological products and vaccines->14.5 Immunoglobulins Normal immunoglobulin Restricted 14 Immunological products and vaccines->14.5 Immunoglobulins- >14.5.1 Normal immunoglobulin NORMAL IMMUNOGLOBULIN Restricted

14 Immunological products and vaccines->14.5 Immunoglobulins- >14.5.1 Normal immunoglobulin->NORMAL IMMUNOGLOBULIN For intravenous use Restricted

14 Immunological products and vaccines->14.5 Immunoglobulins- >14.5.3 Anti-D (Rh0) immunoglobulin ANTI-D (Rh0) IMMUNOGLOBULIN NICE-approved 14 Immunological products and vaccines->14.5 Immunoglobulins- >14.5.3 Anti-D (Rh0) immunoglobulin->ANTI-D (Rh0) IMMUNOGLOBULIN Rhophylac® Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous Drugs used for intravenous anaesthetics anaesthesia Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs used for intravenous anaesthesia ETOMIDATE Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs used for intravenous anaesthesia Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs used for intravenous anaesthesia PROPOFOL Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs used for intravenous anaesthesia THIOPENTAL SODIUM Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs used for intravenous anaesthesia->ETOMIDATE Etomidate-Lipuro® Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs used for intravenous anaesthesia->KETAMINE Ketalar® Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status

15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs used for intravenous anaesthesia->PROPOFOL Diprivan® On Formulary

15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs used for intravenous anaesthesia->PROPOFOL Propofol On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.1 Intravenous anaesthetics->Drugs used for intravenous anaesthesia- >THIOPENTAL SODIUM Thiopental Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.2 Inhalational anaesthetics Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.2 Inhalational anaesthetics Volatile liquid anaesthetics Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.2 Inhalational anaesthetics->Nitrous oxide NITROUS OXIDE Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.2 Inhalational anaesthetics->Volatile liquid anaesthetics DESFLURANE Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.2 Inhalational anaesthetics->Volatile liquid anaesthetics Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.2 Inhalational anaesthetics->Volatile liquid anaesthetics Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.3 Antimuscarinic drugs ATROPINE SULFATE On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.3 Antimuscarinic drugs HYOSCINE HYDROBROMIDE On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.3 Antimuscarinic drugs Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.3 Antimuscarinic drugs->ATROPINE SULFATE Atropine On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.3 Antimuscarinic drugs->GLYCOPYRRONIUM BROMIDE Glycopyrronium bromide Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.3 Antimuscarinic drugs->GLYCOPYRRONIUM BROMIDE With neostigmine metilsulfate Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.3 Antimuscarinic drugs->HYOSCINE HYDROBROMIDE Hyoscine On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.1 Benzodiazepines DIAZEPAM On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.1 Benzodiazepines LORAZEPAM On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.1 Benzodiazepines TEMAZEPAM On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.1 Benzodiazepines MIDAZOLAM Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.1 Benzodiazepines- >MIDAZOLAM Midazolam On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.2 Non-opioid analgesics KETOROLAC TROMETAMOL Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.3 Opioid analgesics ALFENTANIL Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.3 Opioid analgesics FENTANYL Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.3 Opioid analgesics REMIFENTANIL Restricted

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 15 Anaesthesia->15.1 General anaesthesia->15.1.4 Sedative and analgesic peri-operative drugs->15.1.4.3 Opioid analgesics- >FENTANYL Fentanyl Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Depolarising neuromuscular blocking drugs SUXAMETHONIUM CHLORIDE Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Depolarising neuromuscular blocking drugs- >SUXAMETHONIUM CHLORIDE Suxamethonium Chloride Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Non-depolarising neuromuscular blocking drugs ATRACURIUM BESILATE Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Non-depolarising neuromuscular blocking drugs MIVACURIUM Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Non-depolarising neuromuscular blocking drugs PANCURONIUM BROMIDE Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Non-depolarising neuromuscular blocking drugs ROCURONIUM BROMIDE Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Non-depolarising neuromuscular blocking drugs VECURONIUM BROMIDE Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Non-depolarising neuromuscular blocking drugs- >ATRACURIUM BESILATE Atracurium Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Non-depolarising neuromuscular blocking drugs- >MIVACURIUM Mivacron® Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.5 Neuromuscular blocking drugs->Non-depolarising neuromuscular blocking drugs- >PANCURONIUM BROMIDE Pancuronium Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.6 Drugs for reversal of neuromuscular blockade->Anticholinesterases EDROPHONIUM CHLORIDE Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.6 Drugs for reversal of neuromuscular blockade->Anticholinesterases NEOSTIGMINE METILSULFATE Restricted

15 Anaesthesia->15.1 General anaesthesia->15.1.6 Drugs for NEOSTIGMINE WITH reversal of neuromuscular blockade->Anticholinesterases GLYCOPYRRONIUM BROMIDE Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.6 Drugs for reversal of neuromuscular blockade->Anticholinesterases- >EDROPHONIUM CHLORIDE Edrophonium Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.6 Drugs for reversal of neuromuscular blockade->Anticholinesterases- >NEOSTIGMINE METILSULFATE Neostigmine Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.6 Drugs for reversal of neuromuscular blockade->Other drugs for reversal of neuromuscular blockade SUGAMMADEX Restricted 15 Anaesthesia->15.1 General anaesthesia->15.1.7 Antagonists for central and respiratory FLUMAZENIL On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.7 Antagonists for central and respiratory depression HYDROCHLORIDE On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.7 Antagonists for central and respiratory depression->FLUMAZENIL Flumazenil On Formulary

This formulary was published on 8th January 2014

Formulary Sec tion Title Status 15 Anaesthesia->15.1 General anaesthesia->15.1.8 Drugs for malignant hyperthermia DANTROLENE SODIUM On Formulary 15 Anaesthesia->15.1 General anaesthesia->15.1.8 Drugs for malignant hyperthermia->DANTROLENE SODIUM Dantrium Intravenous® On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Bupivacaine BUPIVACAINE HYDROCHLORIDE On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Bupivacaine- >BUPIVACAINE HYDROCHLORIDE Bupivacaine On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Bupivacaine- >BUPIVACAINE HYDROCHLORIDE->With adrenaline Bupivacaine and Adrenaline On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Levobupivacaine LEVOBUPIVACAINE On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Lidocaine LIDOCAINE HYDROCHLORIDE On Formulary

15 Anaesthesia->15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE Lidocaine hydrochloride injections On Formulary

15 Anaesthesia->15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE Lidocaine injections for dental use Restricted 15 Anaesthesia->15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE->Lidocaine for surface anaesthesia Instillagel® On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE->Lidocaine for surface anaesthesia Laryngojet® On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE->Lidocaine for surface anaesthesia LMX 4® On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE->Lidocaine for surface anaesthesia Xylocaine® On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE->Lidocaine for surface anaesthesia Versatis® Restricted 15 Anaesthesia->15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE->Lidocaine hydrochloride injections Lidocaine On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Lidocaine->LIDOCAINE HYDROCHLORIDE->With adrenaline Xylocaine® On Formulary 15 Anaesthesia->15.2 Local anaesthesia->Prilocaine PRILOCAINE HYDROCHLORIDE Restricted 15 Anaesthesia->15.2 Local anaesthesia->Prilocaine->PRILOCAINE HYDROCHLORIDE For dental use Restricted 15 Anaesthesia->15.2 Local anaesthesia->Ropivacaine ROPIVACAINE HYDROCHLORIDE Restricted 15 Anaesthesia->15.2 Local anaesthesia->Tetracaine TETRACAINE Restricted

This formulary was published on 8th January 2014

Top View